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ABSTRACT
Purpose: The purpose of this investigation was to examine the effects of SR2W-1
herbal supplementation on cycling performance, muscle and blood lactate, and
various physiological parameters including blood glucose, heart rate (HR), rating
of perceived exertion (RPE), oxygen consumption (VO2), expired ventilation
(VE), respiratory exchange ratio (RER), and femoral artery blood flow. Methods:
Seven recreational cyclists (Age: 26.7 ± 9.8 yrs, Height: 172.5 ± 13.3 cm, Weight:
67.1 ± 10.7 kg, and VO2max: 59.5 ± 11 mL/kg/min) performed 20-min of steadystate cycling (~85% VO2max, 212.1 ± 25.0 W) followed by three 1-min high
intensity intervals at VO2max workload (272.9 ± 26.9) with 30-sec active recovery
periods at 100 watts.

Following intervals, a 15-min passive recovery period

preceded a ride to fatigue at VO2max workload. Subjects completed trials on four
occasions; preceding and following 21 days of 1000mg/d SR2W-1 (EXP) or
1000mg/d placebo (PLA) assigned in random order. The Wilcoxon Signed-Rank
Test was used to compare change-scores from pre- to post- PLA and EXP
conditions.

Results: No differences reported for any dependent variable and

performance times were not different between PLA (pre-PLA: 180 ± 48 s; postPLA: 198 ± 56 s) and EXP (pre-EXP: 170 ± 57 s; post-EXP: 191 ± 50 s).
Conclusion: Notwithstanding the small sample size, 3 weeks of SR2W-1
supplementation does not appear to aid cycling performance, attenuate skeletal
muscle fatigue, or modify general physiological responses to exercise.
vi

CHAPTER ONE
INTRODUCTION
Following the pioneering work of A.V. Hill and others, the Harvard
Fatigue Laboratory opened in the fall of 1927 in Cambridge, Massachusetts with
the purpose of examining fatigue in man under various environmental and
working conditions.

Although the lab is no longer in existence, the complex

nature of fatigue has necessitated continued work in this area, especially as it
relates to fatigue from exercise. Of the many physiological parameters implicated
in exercise-induced fatigue, hydrogen concentration (pH) and lactate are two of
the most widely studied.
High levels of blood lactate and associated reductions in pH are strongly
associated with the onset of fatigue. In 1907, Fletcher and Hopkins examined
lactic acid levels in working frog muscles and stated that “an acid reaction of the
muscle is, as most agree, a constant mark of the fatigued condition and a constant
condition of the state of rigor,” providing evidence that acidity has been
associated with decreased function and fatigue for over a century (33).

The

relationship between exercise-induced blood acidity and intensity in man was
elucidated by Margaria et al. in 1933 (63). It is now known that carbohydrate
metabolism (glycolysis) increases with exercise intensity to rapidly re-synthesize
ATP for contracting skeletal muscle. A high rate of glycolysis leads to pyruvate
production that exceeds the speed at which pyruvate can be aerobically
metabolized in the mitochondria, thus resulting in the ‘anaerobic’ formation of
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lactic acid. Once lactic acid is formed it immediately dissociates into lactate and
hydrogen which contributes to a decrease in muscle and blood pH (Figure 1.1).

Whole muscle
Aerobic Glycolysis

Carbohydrate
Anaerobic Glycolysis

Pyruvic Acid

Lactic acid
Hydrogen accumulation
interferes with function
and may cause fatigue

Lactate H+

Pyruvate

Interstitium
Co-transport of lactate and H+ into
blood allows for continued
muscular function

Vein

H+/Lactate

Bloodflow

Figure 1.1 - Lactate Dynamics
Lactic acid’s role in fatigue has been debated due to a lack of supporting
evidence regarding lactic acid’s proton contribution and the positive energetic
properties of lactate. However, the deleterious effects of pH on skeletal muscle
function are well-documented. In-vitro skeletal muscle experiments have shown
that low intra-muscular pH can interfere with several reactions within the muscle
cell, inhibiting function and causing fatigue (13, 30, 59).

It has also been

suggested that hydrogen ion accumulation may inhibit the release of calcium from
the sarcoplasmic reticulum and interfere with the transmission of neural impulses
which can also decrease function (45). Although there are other potential sources
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of muscular fatigue which can hinder performance such as fatigue of the central
nervous system, psychological factors, and inorganic phosphate accumulation in
the muscle cell, acidosis is often regarded as the most prevalent source of fatigue
during intense exercise.
Because intense exercise is associated with a drop in pH and subsequent
fatigue, athletes can benefit from strategies that mitigate the acidifying effect of
exercise to enhance their performance.

In 1924, A.V. Hill acknowledged the

importance of tissue and blood buffers and their effect on muscular effort (39).
As early as the 1930’s, researchers experimented with induced alkalosis and its
effect on performance. They hypothesized that by increasing blood alkalinity,
more lactic acid could be produced implying more energy from anaerobic
glycolysis and achievement of higher intensities (64). After being largely ignored
for nearly 30 years due to initial null findings, a resurgence of research in the
1970‘s began to indicate that manipulating extracellular buffering capacity can
impact intracellular pH. Bicarbonate supplementation became the predominant
mode of inducing blood alkalinity since the bicarbonate buffer system is a
primary source of blood’s buffering capacity.

Research shows that increasing

blood pH with bicarbonate increases the rate of lactate and hydrogen efflux from
muscle cells despite the sarcolemma’s relative impermeability to bicarbonate (18,
43, 48, 88, 92). This suggests that hydrogen ion efflux from the cell works down
a concentration gradient.

Conceptually, an increased concentration gradient

facilitated by changes in extracellular lactate/H+ should allow for more lactate/H+
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transport from the active skeletal muscle, thereby delaying fatigue. As a result,
lactate/H+ supplement research has become prevalent due to its potential
performance-enhancing benefits.
SR2W-1 is a commercially available herbal supplement designed to
improve high-intensity exercise performance. Research supporting the efficacy of
SR2W-1 is promising as two investigations have demonstrated that SR2W-1
prolongs exercise endurance and promotes lactate clearance after exhaustive
exercise as well as improves overall performance (1, 57). However, the two
existing SR2W-1 studies were not peer reviewed nor were they cross-over,
placebo-controlled, double-blind designs examining multiple factors.

The

comprehensive nature of our studies’ protocol is more likely to reveal a
mechanism of action.

If the ergogenic effects of SR2W-1 are facilitated by

factors related to acid-base balance, the effects are likely mediated by one or both
of the following physiological mechanisms: 1. Direct effect on lactate and
hydrogen production in skeletal muscle or intracellular buffering, and 2. Indirect
effect on skeletal muscle lactate and pH through modifications to blood lactate
and/or pH. Although there has been a sparse amount of information gathered on
the effects of herbal supplements on blood flow, the latter mechanism could be a
result of blood flow distribution due to it’s role in lactate exchange (34, 96).

5

Aims and Hypotheses
Aim 1 - To determine if 21 days of SR2W-1 supplementation improves highintensity cycling performance compared to a placebo.
Hypothesis 1 - SR2W-1 will improve cycling exercise performance compared to a
placebo.
Aim 2 - To determine if 21 days of SR2W-1 supplementation alters blood lactate
levels during cycling exercise compared to a placebo.
Hypothesis 2 - SR2W-1 will reduce blood lactate levels during exercise compared
to a placebo.
Aim 3 - To determine if 21 days of SR2W-1 supplementation alters blood lactate
levels during 15 minutes passive recovery compared to a placebo.
Hypothesis 3 - SR2W-1 will reduce blood lactate levels during high-intensity
intervals when compared to a placebo.
Aim 4 - To determine if 21 days of SR2W-1 supplementation alters skeletal
muscle lactate levels during 15 minutes of passive recovery compared to a
placebo.
Hypothesis 4 - SR2W-1 will decrease skeletal muscle lactate levels and increase
muscle pH compared to a placebo.
Aim 5 - To determine if SR2W-1 alters femoral artery blood flow during 15
minutes of passive recovery compared to a placebo.
Hypothesis 5 - SR2W-1 will increase femoral artery blood flow when compared to
a placebo.
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Significance of the Study
Although initial studies have indicated that SR2W-1 supplementation has
positive effects on lactate levels and performance, the current study will be the
first to implement a randomized, placebo-controlled, cross-over design. Thus, the
finding will provide a strong scientific foundation for the relative efficacy of the
supplement which will serve to better inform coaches and athletes. Further, the
physiological effect of SR2W-1, combined with the performance outcome, will
provide further insight in to the role of blood flow, blood lactate and pH, and
skeletal muscle lactate and pH as factors in fatigue.

CHAPTER TWO
REVIEW OF THE LITERATURE
Objectives
The objectives of this chapter are to provide an overview of how: 1)
lactate affects skeletal muscle fiber function in animals independent of pH, 2) pH
affects skeletal muscle fiber function in animals, 3) lactate and pH affects cycling
and leg exercise in man, 4) sodium bicarbonate/citrate supplementation affects
cycling performance and, 5) herbal supplementation affects cycling performance.

Lactate and Skeletal Muscle Fiber Contractile Function in Animals
Lactate and hydrogen ions are by-products of anaerobic glycolysis,
produced in excess when exercise intensity exceeds the aerobic system’s ability to
provide energy. Once lactate is produced in the cytoplasm of a muscle cell (fiber)
it is: 1) released into the blood and used by the liver as a gluconeogenic precursor
2) shuttled to an adjacent muscle fiber and used for immediate energy provision or
stored as glycogen, 3) released into the blood and taken up by other skeletal
muscle fibers and the heart, or 4) excreted in urine or sweat.

The production of

hydrogen ions is generally associated with fatigue while lactate itself is
considered a fuel. However, some research does indicate that lactate may inhibit
muscle function independent of pH in animal fibers.
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Research on the effects of lactate concentration on the contractile
machinery, and consequently force production, is contentious.

Two studies

concluded that lactate has no effect on excitation-contraction coupling (22, 79)
and may actually promote the maintenance of submaximal and maximal dynamic
force and maximal isometric force (49). However, other studies have shown that
lactate significantly decreases tetanic force (5, 87) and tension development of
animal muscle fibers (28, 40).
On a mechanistic level, numerous studies have examined the influence of
lactate concentration on the functionality of animal sarcoplasmic reticulum (SR),
a muscle fiber organelle responsible for releasing the calcium necessary for
contraction. Andrews et al. found that lactate exposure reduces calcium uptake of
the SR which could theoretically decrease calcium availability for contraction for
subsequent contractions (6). Lactate has also been shown to inhibit both caffeineinduced calcium release (22, 32) and calcium-induced calcium release by the
sarcoplasmic reticulum (32), thus interfering with contractile function.

In

contrast, others have indicated that lactate either increases calcium-induced
calcium release (6) or has no effect on the normal voltage-gated calcium release
of the sarcoplasmic reticulum (22) since the physiological mechanism of calcium
release is different than artificially induced mechanisms. More research is needed
to determine the role of lactate on calcium dynamics of the SR.
Although mechanisms for how lactate may inhibit muscle function have
not been identified and lactate’s role as a source of fuel is widely accepted, there
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is still some evidence suggesting that the lactate anion may contribute to the
skeletal muscle fatigue process. However, research regarding the effect of high
intracellular lactate on human muscle function in vitro is lacking and translating
animal findings to human models is speculative, albeit not completely unrealistic.
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Table 2.1: Lactate and Skeletal Muscle Fiber Contractile Function in
Animals
Author/
Year

Species &
Muscle

Design

Findings

Hogan et al.
1995 (40)

Dog Gastroc

• Infused with either
[La+] or placebo in situ
• Muscle stimulated via
sciatic nerve for two 60minute period with 45minute rest in a step-wise
fashion

• ↑ [La+] ↓ tension
development in
proportion with a change
in muscle oxygen uptake

Andrews et
al. 1996 (5)

Rabbit Psoas and
Soleus

• Chemically skinned SMF
bathed in varying [La+]
concentrations within
physiological and
supraphysiological range
for rabbits and humans

• ↑ [La+] ↓ Ca2 +
activated force in fasttwitch psoas and slowtwitch soleus
• In supraphysiological
[La+] conditions (30-50
mM), force returned to
control levels
• ↑ [La+] ↓ muscle
function and force of
contractile apparatus,
responsible for up to 1/3
of force depression

Favero et al.
1997 (32)

Rabbit Hindleg
and Back

• SR vesicles extracted

• ↑ [La+] ↓ Ca2 + and

Andrews and
Nosek 1998
(6)

Rat Extensor
Digitorum
Longus

Ca2 + efflux,

• Quantified
ryanodine binding, and
single Ca2 + channel
dynamics in varying [La
+] environments

caffeine induced Ca2+
release
• ↑ [La+] ↓ Ca2 +dependent binding of
ryanodine to its receptor
• ↑ [La+] ↓ singlechannel caffeineactivated Ca2 + release

• SMF bathed in varying

• SR Ca2 + uptake ↓ most

[La+] concentrations
• SR loaded and depleted
under different [La+]
conditions

with 10 mM [La+] and
less with 20 and 30 mM
up to 60 seconds
exposure
• Ca2 + induced Ca2 +
release ↑ as [La+] ↑ at
pCa 5 but not pCa > 8.5
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Table 2.1: Lactate and Skeletal Muscle Fiber Contractile Function in
Animals (continued)
Author/
Year

Species &
Muscle

Design

Findings

Spangenburg
et al. 1998
(87)

Mouse
Extensor
Digitorum
Longus

• Muscle incubated
in 10, 20, 30, and
50 mM [La+] at 21
and 37 °C
• Force output
monitored

• ↓ tetanic force at ↑ extracellular
[La+] levels especially at higher
temperature
• ↑ [La+] ↓ rate of Ca2+ release

Dutka and
Lamb 2000
(22)

Rat Extensor
Digitorum
Longus and
Toad
Iliofibularis

• Skinned SMF
bathed in varying
[La+]
concentrations
• Contractile
apparatus, caffeineinduced Ca2 +
release from SR,
and depolarization
induced Ca2 +
release evaluated

• [La+] small ↓ on contractile
apparatus
• [La+] ↓ caffeine-induced Ca2 +
release
• [La+] ↔ Ca2 + release from
normal voltage gate mechanism
• No real inhibitory effect on
excitation-contraction coupling

Posterino and
Fryer 2000
(80)

Rat Extensor
Digitorum
Longus and
Soleus

• Skinned SMF

• [La+] ↓ maximum Ca2 + activated

bathed in varying
[La+]
concentrations
• Quantified effect of
[La+] on
contractile
function, voltage
dependent Ca2 +
release, and Ca2 +
leak from SR

force, Ca2 + sensitivity
• [La+] ↑ Ca2 + leak from SR
• Inhibitors of [La+] transport did not
alter effect of [La+] on excitationcontraction coupling
• [La+] has small effect on Ca2 +
release, Ca2 + handling, and
contractile process

Posterino et
al. 2001 (79)

Rat Extensor
Digitorum
Longus

• Skinned SMF
bathed in varying
[La+]
concentrations
• Measured Ca2 +
uptake, contractile
apparatus function,
twitch and tetanic
force in presence
of [La+]

• [La+] ↔ Ca2 + activation of
contractile apparatus, rate of rise
or peak twitch and tetanic
response, Ca2+ release of action
potential, and Ca2 + uptake of SR
• [La+] ↔ excitation-contraction
coupling
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Table 2.1: Lactate and Skeletal Muscle Fiber Contractile Function in
Animals (continued)
Author/
Year

Species and
Muscle

Design

Findings

Erdogan et al.
2002 (28)

Rat Diaphragm

• Muscle strips bathed in
20 mM
[La+] or placebo for
20 minutes
• Muscle stimulated via
phrenic nerve
• Evaluated resting
membrane potential
and amplitude of
sarcolemma action
potential

• [La+] ↓ mean tension
development
• [La+] ↔ resting
membrane potential or
amplitude of
sarcolemma action
potential

Karelis et al.
2004 (49)

Rat Plantaris

Whole muscle bathed in
saline or [La+] solution
and stimulated for 60
minutes

• [La+] infusion
preserved submaximal
dynamic force
• Maximum dynamic and
isometric force higher
at end of stimulation
period with [La+]
• [La+] ↔ muscle
glycogen utilization or
neuromuscular fatigue

SMF = Single Muscle Fiber, SR = Sarcoplasmic Reticulum, [La+] = Lactate
Concentration, Ca2 + = Calcium, mM = Millimole, ↑ = Increase, ↓ = Decrease, ↔
= No Change
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pH and Skeletal Muscle Fiber Contractile Function in Animals
pH is the negative logarithm of hydrogen ions in solution. In other words,
pH describes how acidic or basic a solution is. At rest, human skeletal muscle
operates optimally at approximately 7.0 pH units.

Heavy muscular work (i.e.

exercise) disrupts homeostasis by reducing pH. Numerous studies have evaluated
whether or not decrements in skeletal muscle pH impact function of various
animals in vivo and in vitro. In 1906, Fletcher and Hopkins were amongst the first
to identify that “lactic acid,” or an acidified condition of the muscle, affected the
muscular function of amphibians. Since then, many studies have been conducted
with various animals, most of which finding that muscle acidification diminishes
both muscle contractile velocity (16, 19, 24, 78, 98, 100) and peak isometric force
(21, 30, 78, 90).

Additionally, the rate of relaxation and force recovery also

appears to be impaired in fatigued and acidified skeletal muscle (12, 82, 98).
Although acidosis may contribute to fatigue, Nielsen et al. speculated that it might
be a protective strategy due to its beneficial contributions to force recovery in the
presence of elevated potassium (75). This hypothesis is attractive, but Krisensen
et al. found that acidosis is not protective under normal physiologic conditions
(55).
A primary weakness of the existing in vitro animal data is that experiments
are typically performed at non-physiological temperatures which makes
interpreting the generalizability of findings difficult.

For instance, both

Westerblad et al. and Pate et al. found that acidification of animal muscle below
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physiological

temperatures significantly reduced maximum shortening velocity

while at normal temperature shortening velocity is actually slightly increased (78,
98). There is also evidence that induced acidosis during experimentation does not
mimic acidification caused by muscle fatigue from stimulation since there is a
smaller decrease in stiffness of muscle when acidification is artificially created
(24). Thus, methodological limitations make it difficult to apply these findings to
in vivo human skeletal muscle function.
From a mechanistic standpoint there are many explanations for how
lowered pH could induce muscle fatigue in animals.

Calcium release from

sarcoplasmic reticulum (SR) vesicles has been shown to decrease during acidosis
and high-lactate conditions through the Ryanodine calcium channel, a very
specific channel in which binding is governed by compounds that stimulate
calcium release and inhibition (31, 61). However, other research using whole
muscle fibers has shown that pH does not decrease calcium release from the SR,
may leak more calcium in an acidotic state, and increase the amount of tetanic
calcium available (14, 58).

Regardless of calcium availability, lowered pH

reduces calcium re-uptake time from the myoplasm creating a longer duration of
depolarization-induced response (58) and greatly reduces binding of calcium to
troponin C, which inhibits the contractile machinery (14, 21, 30).

Finally, an

acidified intramuscular condition may affect certain reactions in the glycolytic
cascade, which could inhibit function.

In mouse and frog muscle,

phopshofructokinase (PFK) is very sensitive to pH changes and acidosis reduces

15

the affinity of PFK for fructose-6-phosphate (4, 93). An abundance of research
implicates pH as a cause of fatigue but the exact role of pH is unknown.
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Table 2.2: pH and Skeletal Muscle Fiber Contractile Function in Animals
Author/
Year

Subjects

Design

Findings

Fletcher
and
Hopkins,
1906 (33)

Amphibian
Limb

• Frog limb muscles
stimulated electrically in
different anaerobic
environments (hydrogen and
nitrogen) at varying
temperatures
• “Lactic acid” measures and
muscle weights taken at
different time points

• ↑ “lactic acid” levels ↓
muscle function
• Muscle function ceased at
certain pH levels and
temperatures

Trivedi and
Danforth
1966 (93)

Mouse
Gastrocnemius

• PFK extracted and placed in
solution
• pH altered within
physiological range

• ↓ pH, ↓ affinity of PFK
for F-6-P
• PFK is very sensitive to
pH changes

Donaldson
1977 (21)

Rabbit Soleus
and Adductor
Magnus

Skinned SMF stimulated in
Ca2+ buffer solutions of
consistent chemical
composition at pH 6.5 or 7.0
and 1 mM or 7 mM of Mg2+

• ↔ Maximum tension at
the same Mg2+
concentration but ↓ at
lower pH
• Greater ↓ of submaximal
force at 1 mm Mg2+ in
acidotic conditions

Fabiato
1978 (30)

Frog
Semitendinosus
(skinned)

Skinned SMF stimulated in
solutions of varying free Ca2+
and pH

• Small acidosis ↑ Ca2 +
content of SR and large
acidosis ↓ Ca2 + content
• Acidosis ↓ maximum
tension production
• H+ accumulation affected
force production despite
Ca2+ saturation

Renaud and
Mainwood
1985 (82)

Frog Sartorius

Muscles stimulated at
different rates (0.2 - 2 trains/
second) in various
extracellularly buffered
solutions

• ↓ extracellular pH ↓ the
rate of force recovery
• ↔ rate of change from a
normal to fatigued state

Spriet 1985
(90)

Rat
GastrocnemiusPlantarisSoleus
Complex
(Hindquarter)

• Whole muscle stimulated in
control condition (C),
metabolic acidosis (MA), or
respiratory acidosis (RA)
• Bx pre and post perfusion
• Analyzed for PPO2, PPCO2,
pH, O2 saturation of Hb, Hb
concentration, plasma
HCO3-, arterial Hct, ATP,
ADP, AMP, CP, and [La+]

• [La+] release greatest in C
• Muscle Gly utilization and
[La+] accumulation ↓ in
MA and RA
• ↔ Muscle CP and ATP
• Acidosis ↓ isometric
tension, aerobic, and
anaerobic metabolism
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Table 2.2: pH and Skeletal Muscle Fiber Contractile Function in Animals
(continued)
Author/
Year

Subjects

Design

Findings

Cooke 1987
(16)

Rabbit Psoas

• SMF stimulated in buffers of
differing pH, temperature,
and chemical composition to
determine MgATP, NADH,
and ATPase activity

• ↓ pH at 3 mM PO4 ↓

Metzger and
Fitts 1987 (71)

Rat
Diaphragm

• Muscle strips bathed in
Ringer solution in
temperature-controlled
chamber
• Stimulated to fatigue at high
and low frequencies and time
intervals
• Intracellular pH measured

• ↔ high low frequency

Curtin 1988
(19)

Frog Anterior
Tibialis

• SMF perfused in Ringer
solution of varying pH (6.00
- 7.99) and constant HCO3
• Intracellular pH and
temperature measured

↑ fiber acidity, ↓ force

Edman 1990
(24)

Frog Anterior
Tibialis

• SMF placed in standard or pH
lowering solution at constant
temperatures
• Stiffness measured
throughout isometric tetanus
• SMF fatigued via continual
stimulation or chemical
solution
• Caffeine introduced to
determine whether failure of
activation of contractile
system caused fatigue

• Chemical and
mechanical fatigue did
not duplicate contractile
behavior of fatigued
muscle
• Smaller stiffness ↓ from
artificially lowered pH
versus fatigue
• Induced acidification ↑
rate of rise of stiffness
with ↓ rise of force
• Force-producing
capability of attached
cross bridges ↓ in
fatigued condition
despite ↔ in activation

PO4 by 45%, ↓
maximum velocity of
contraction, ↓ ATPase
activity by 25-30%
• Curve of the forcevelocity relationship ↔
with PO4 or pH changes

groups and recovery of
pH
• Recovery of pH highly
correlated to the
recovery of peak tetanic
tension
• Fatigue from high and
low frequency partially
due to effects of
intracellular acidosis on
excitation-contraction
coupling

and heat
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Table 2.2: pH and Skeletal Muscle Fiber Contractile Function in Animals
(continued)
Author/
Year

Subjects

Amorena 1990
(4)

Frog
Semitendinosus

Lamb 1992
(58)

Design

Findings

• Fiber bundles superfused
in acid or control
solutions at 22°C
• Electrodes monitored pH
• SMF analyzed for ATP,
CP, G-6-P, and F-6-P

Acidosis slowed glycolysis
by ↓ conversion of F-6-P
to F-1,6-DP and inhibiting
PFK enzyme

Skinned Toad
Iliofibularis

• SMF placed in Ca2+, Na,
K+ solutions and
stimulated chemically in
activating solutions to
elicit depolarizationinduced response
• Ca2+ uptake and leakage
from the SR at different
pH evaluated by bathing
SMF in different pH
solutions and depolarizing
at normal pH

•↓ pH, SR can not uptake

Favero 1995
(31)

Rabbit Hindleg
and Back White
Skeletal

• Extracted SR vesicles
placed in buffer solution
at pH 7.1-6.5
• Ca2+ efflux measured via
effluxing agent and dualwavelength
spectrophotometer
• To measure [H]
Ryanodine binding, SR
membranes incubated in
chemical medium,
introduced to various
channel-modifiers, placed
in scintillation cocktail,
shaken overnight, and
analyzed

• Decreasing pH ↓ [H]
Ryanodine binding
regardless of other
experimental conditions
• [La+] is strong inhibitor
of [H]Ryanodine binding

Pate 1995 (78)

Rabbit Psoas

• Skinned SMF buffered to
pH of 7.0 or 6.2
• SMF stimulated at either
30°C (physiological
condition) or 10°C

• At 10°C in acidified
condition, maximum
velocity of shortening
and isometric tension
significantly ↓
• At 30°C, maximum
velocity of shortening
slightly ↑ while

Ca2+ as rapidly from
myoplasm creating
longer duration of
depolarization-induced
response
• Acidosis ↑ Ca2+ leak
from SR and releases less
calcium with
depolarization
• ↓ pH has little effect on
depolarization-induced
Ca2+ release

isometric tension still ↓
while acidified
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Table 2.2: pH and Skeletal Muscle Fiber Contractile Function in Animals
(continued)
Author/
Year

Subjects

Design

Findings

Wiseman
1996 (100)

Mouse Hindlimb
and Rabbit Psoas

• Whole mouse extensor
digitorum longus used
to measure pH changes
during stimulation and
rabbit psoas SMF used
to control proton
concentration and
manipulate temperature
• Whole muscle and SMF
bathed in normocapnic
or hypercapnic solution,
stimulated electrically at
13 to 25°C

• Hypercapnia ↓ pH at 15
and 25°C but force
inhibition greater at lower
temperatures in mouse
muscle
• ↔ Temperaturedependent inhibition of
force in individual rabbit
fibers at maximum Ca2+
activation
• Temperature affects
inhibitory action of pH on
muscle function

Westerblad
1997 (98)

Mouse Flexor
Brevis

• SMF perfused in Tyrode
control, acidifying, or
alkalanizing solution
• Muscles stimulated at
either 12, 22, or 32°C
(all below physiological
temperature)
• Fluorescent pH indicator
SNARF-1 used to
measure pH

• In acidified fibers, force ↓
more at lower
temperatures than at 32°C
• Acidification slowed
relaxation but mitigated
by ↑ temperature
• Shortening velocity ↓
with acidification and low
temperature but ↔ at
32°C

Bruton 1998
(12)

Rat Flexor Brevis

• SMF perfused in 30%
CO2 environment at
28°C (acidified
condition)
• SMF stimulated until
force declined to 40% of
control’s force
production
• pH analyzed via
fluorescent probe

• Intracellular acidification

Chin 1998
(14)

Mouse Flexor
Brevis

• SMF perfused in
solution designed to
determine intensity
dependence of pH and
pH dependent
mechanisms of fatigue
• Muscle stimulated at
different intensities to
induce fatigue

• Ca2+ release by SR ↑

↔

tetanic force
production or number of
stimulations required to
induce fatigue
• Low pH ↓ relaxation rate
of muscle

with ↑ acidosis and
fatigue
• Ca2+ sensitivity of
contractile proteins ↓
with large acidosis
• Ca2+ release failure does
not require nor is
augmented by acidosis
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Table 2.2: pH and Skeletal Muscle Fiber Contractile Function in Animals
(continued)
Author/
Year

Subjects

Design

Findings

Laver 2000
(61)

Rabbit
Skeletal

• Extracted SR vesicles
incorporated into lipid
bilayer membrane to study
Ryanodine (RyR) receptor
Ca2+ release channels
• pH altered and cytoplasmic
and luminal pH studied in
the pH range of 5-8

Acidic cytoplasmic pH ↓
RyR activity while luminal
pH inhibited at much lower
pH values (5-5.5)

Nielsen 2001
(75)

Rat Soleus

• Whole muscle incubated in
K+ solution and affixed to
force transducer
• Muscles stimulated through
motor nerve and analyzed
for membrane potential,
Ca2+ influx, Ca2+ content,
Na+/K+ pump activity, and
intracellular pH
• Lactic acid added to isolated
muscle whose force had
been depressed by elevated
K+

• Addition of lactic acid
recovered force more
quickly and prevented
reduction in force when
introduced with
K+
• Acidification may be
protective during highintensity exercise when
extracellular K+
accumulates to potentially
inhibitory levels

Kristensen
2005 (55)

Rat Soleus

• Isolated muscle placed in
lactate, high K+, or
bicarbonate-free medium
and stimulated electrically
• Role of pH on K+ uptake
rate observed

• Study performed in
response to Nielsen et al.
• Lactate and lactic acid
incubation lead to force
recovery in K+ depressed
in vitro muscle
• In vivo mechanism is not
as such and lactate/lactic
acid is not protective

PFK = Phosphofructokinase, F-6-P = Fructose-6-Phosphate, G-6-P = Glucose 6
Phosphate, Mg2+ = Magnesium, mM = Millimole, Ca2+ = Calcium, Na+ =
Sodium, K+ = Potassium, SR = Sarcoplasmic Reticulum, H+ = Hydrogen, Bx =
Biopsy, PPO2 = Partial Pressure of Oxygen, PPCO2 = Partial Pressure of Carbon
Dioxide, O2 = Oxygen, Hb = Hemoglobin, HCO3- = Bicarbonate, Hct =
Hematocrit, ATP = Adenosine Triphophate, ADP = Adenosine Monophosphate,
AMP = Adenosine Monophosphate, Lac = Lactate, CP = Creatine Phosphate,Gly
= Glycogen, NADH = Nicotinamide Adenine Dinucleotide, PO4 = Phosphate,
SMF = Single Muscle Fiber, F-1,6-DP = Fructose-1,6-Diphosphate, ↑ = Increase,
↓ = Decrease, ↔ = No Change
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The Impact of pH and Lactate on Cycling, Leg Kicking, and Isometric
Exercise in Man
As early as 1933 it was observed that a fatigued state coincided with lactic
acid accumulation from muscular work in man (63). Since then, the relationship
between intensity and blood and skeletal muscle pH during high-intensity
exercise, specifically cycling exercise, has been well documented (36, 38, 48, 53,
83, 85). When pH declines and lactate increases in working skeletal muscle and
blood during heavy exercise, performance starts declining and fatigue ultimately
forces retirement.
Although the majority of mechanistic research regarding pH and muscle
function has been

performed with animals, a few studies have evaluated the

effects of lowered pH on human muscle fibers in vitro. For example, a reduction
in pH is detrimental to glycolysis during exercise (46, 53), possibly by inhibiting
adenylcylase and phosphorylase b kinase (13) or glycogen phosphorylase (89),
necessary enzymes in the glycolytic cascade. Messonier et al. showed that higher
concentrations of MCT1 and MCT4, hydrogen transport proteins in skeletal
muscle responsible for maintaining acid-base homeostasis, improves cycling
performance, thus demonstration a clear link between pH regulation and fatigue
(70). However, Sahlin et al. reported that force recovers much more quickly than
pH after exhausting leg exercise, implying that pH is not the sole source of
anaerobic muscle fatigue (84).
As previously detailed, lactate is created as a by-product of anaerobic
glycolysis during intense exercise. Even though lactate itself is a fuel and is not
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considered a direct cause of muscle fatigue, measuring blood lactate serves as a
good indicator of the myocellular environment during exercise. Hydrogen ions
are shuttled to the blood via the same carrier as lactate (MCT4) which makes
lactate an indirect measure of pH.

Further, various studies collectively indicate

that lactate is associated with fatigue during high-intensity exercise (2, 9, 41, 50,
97).

However, McCartney et al. documented a smaller lactate accumulation

following exercise with induced acidosis (65). Although it should be emphasized
that associations do not equal causality, the general relationship between muscle
and blood lactate and pH and fatigue suggests that changes in blood and muscle
pH are likely two factors of many that contribute to fatigue during high-intensity
exercise.
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Table 2.3: The Impact of pH and Lactate on Cycling, Leg Kicking, and
Isometric Exercise in Man
Author/
Year

Subjects

Design

Analyses

Findings

Margaria et
al. 1933 (63)

1 healthy
male
subject

• Subjects ran at
different intensities
on different days
• Exercise BS and EG

BS analyzed
for “lactic
acid”
accumulation

↑ exercise intensity,
↑ “lactic acid” in

BS and Bx
analyzed for
pH

Blood and muscle
pH ↓ during
continuous and
intermittent exercise

Hermansen
and Osnes
1972 (38)

2 female
• On bicycle
and 11 male
ergometer or
subjects
treadmill, 40-60 sec
x 5 bouts, 4 minutes
REC between
• BS and quadriceps
Bx post-exercise

blood until fatigue

Klausen 1972
(53)

4 healthy
males

• Supramaximal VO2
test on a cycle
ergometer (T1)
• On separate day,
subjects performed
test again preceded
by 5 minutes of
heavy arm exercise
to elevate blood
[La+] (T2)
• Exercise BS and EG

• Blood lactate
and VO2max
evaluated
• Endurance
time was the
performance
criterion

• ↓ blood pH and ↑
peak lactate with
T2
• ↔ Maximal
aerobic power but
tendency towards
↓ endurance time
• ↓ Anaerobic
glycolysis in T2

Karlsson 1975
(50)

3 male
subjects

• 2 trials separated by
5-7 days:
Exhaustive leg
cycling followed by
exhaustive arm
cycling and vice
versa
• Deltoid and VL Bx
immediately and 5
min after exercise
• BS pre, during, and
post exercise
• Exercise EG

• Bx analyzed
for ATP, CP,
pyruvate,
and Lac
• TTE was
performance
criterion

• Performance ↓ in
following bout of
exercise after rest
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Table 2.3: The Impact of pH and Lactate on Cycling, Leg Kicking, and
Isometric Exercise in Man (continued)
Author/
Year

Subjects

Design

Analyses

Findings

Sahlin 1976
(85)

16 males and
3 women
aged 20-29
years

• Subjects exercised
until exhaustion or at
a % of VO2max
• VL Bx of 12 subjects
post-exercise
• Experiment
conducted twice, one
week apart
• Exercise BS

• BS analyzed
for [La+]
and pH
• Bx analyzed
for pH

• Muscle pH ↓
from 7.08 to
6.60 postexercise and
linearly related
to muscle [La+]
and pyruvate
content
• Muscle [La+] ↑
post-exercise
and ↓
exponentially
during recovery
while pyruvate

↑

Harris 1977
(37)

Jones 1977
(48)

53 healthy
males
between
18-33 years

5 healthy
males

• Subjects performed
isometric quadriceps
exercise or 6 minutes
cycling
• Medial quadriceps Bx
of both groups at
various time points

• Bx analyzed
for ATP,
ADP, AMP,
CP,
pyruvate,
and [La+]

•ATP:ADP ratio
↓ linearly with
[La+]
• CP showed
nonlinear
relationship to
[La+]

• 3 trials: 0.3 g/kg
placebo, NH4Cl
(acidosis), and
NaHCO3
• Subjects
supplemented, rested
3 hours, and cycled at
33 and 66% VO2max
for 20 minutes and
rode to exhaustion at
95% VO2max
• BS pre, during, and
post exercise
• EG measured during
exercise

• BS analyzed
for [La+],
glucose,
glycerol,
FFA, pH,
PPO2,
PPCO2,
and 2,3-DPG
• Endurance
time was
performance
criterion

• [La+] and
endurance time
↑ with
NaHCO3 and ↓
with NH4Cl
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Table 2.3: The Impact of pH and Lactate on Cycling, Leg Kicking, and
Isometric Exercise in Man (continued)
Author/
Year

Subjects

Design

Analyses

Findings

Sahlin 1978
(83)

8 males
aged 23-31
years

• Cycling at pace
selected to cause
fatigue within 6
minutes
• BS pre, during, and
post exercise
• Medial quadriceps
Bx post exercise

• BS analyzed for
[La+], pyruvate,
protein,
electrolytes, and
acid-base
parameters
• Bx analyzed for
water,
electrolytes, [La
+], and acid-labile
CO2

• pH ↓ from
7.00 to 6.4
post exercise
• pH almost
fully
recovered
after 20
minutes rest
and HCO3 still
significantly

• 4 trials, 5 minutes
maximal cycling at
variable work rate
(T1)
• Passive recovery,
active recovery
below anaerobic
threshold, active
recovery above
anaerobic
threshold, or active
recovery above
anaerobic
threshold while
breathing 100%
oxygen
• 5 minutes maximal
cycling (T2)
• Recovery BS

• BS analyzed for
[La+]
• Work output was
performance
criterion

Type of
recovery
affected [La+]
levels but [La+]
↔ work output
during
subsequent
exercise bouts

• 3 trials: 17, 21, or
60% O2 following
equilibration
period
• 10 minutes cycling
at 55% VO2max
and ride to
exhaustion at 90%
• BS pre, during, and
post exercise.
• EG pre and during
exercise

• BS analyzed for
PPO2, PPCO2,
[La+], and pH
• TTE was
performance
criterion

Hypoxia ↑ [La

Weltman 1979
(97)

Adams 1980
(2)

9 males

6 males

↓

+] and ↓ pH,
PPCO2, and
HCO3, and TTE
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Table 2.3: The Impact of pH and Lactate on Cycling, Leg Kicking, and
Isometric Exercise in Man (continued)
Author/
Year

Subjects

Chasiotis
1983 (13)

Hogan 1984
(41)

Sahlin and
Ren 1989
(84)

Analyses

Findings

3 healthy
• Experiment A:
male
subjects’ leg was
subjects age
occluded for 50-60 s
21-19 years
and Bx after
adrenaline infusion
• Experiment B:
isometric
contraction after leg
occlusion and Bx
after adrenaline
infusion

• Bx pH
determined via
homogenizatio
n and microelectrode
• Bx analyzed
for
metabolites,
cyclic AMP,
enzyme
activity,
phosphorylase,
synthetase,
G-6-P, G-1-P,
F-6-P, and Lac

• Cyclic AMP and
phosphorylase
both ↓ in
acidodic
conditions
• Acidic inhibition
of adenylcyclase
and
phosphorylase b
kinase

6 healthy
males

• 3 trials 1 week apart
• 5 minutes at 95%
VO2max, 4 minute
rest period, and ride
to exhaustion at
90% VO2max.
• Trials differed by
varying percent
oxygen inhalation
(16% O2, 21% O2,
or 60% O2) during 5
minutes exercise to
elicit different blood
[La+] levels
• Exercise BS and EG

• BS analyzed
for [La+], pH
and PCO2
• Total power
output during
the 5 minutes
at 95% and
time to
exhaustion
were the
performance
criterion

• Performance time
significantly ↑
for hyerpoxic
condition versus
hypoxic
• H+ and [La+] ↔
at exhaustion
• [La+]
significantly ↑
after 5 minutes of
exercise in
hypoxic
condition

• Isometric quadriceps
contraction at 66%
MVC until force
declined
• Force recovery
measured by
performing short
contractions at
different time
intervals during
REC
• Endurance
measured by timing
initial contraction
• Bx after initial
contraction

• Bx analyzed
for NADH,
IMP, ATP,
ADP, AMP,
CP,
[La+], and G-6P
•Contraction
endurance
time was
performance
criterion

• ↔ force with
low pH but
endurance ↓
• Force restored
more quickly
than endurance
and pH
• pH impaired
capacity to rephosphorylate
ADP, inhibiting
the ATPgenerating
process

16 healthy
males

Design
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Table 2.3: The Impact of pH and Lactate on Cycling, Leg Kicking, and
Isometric Exercise in Man (continued)
Author/
Year

Subjects

Spriet 1989
(89)

7 men and
1 woman

7 healthy
collegeaged male
students

Bangsbo
1996 (9)

Design

Analyses

Findings

• 3 30-second
maximal
isokinetic
cycling bouts at
100 rpm
separated by 4
minutes rest
• VL Bx between
bouts 2 and 3

• Bx analyzed for
glycogen, CP, ATP,
AMP, Glucose,
G-6-P, F-6-P, G-1P, F-1,6-P2,
Glyc-3-P,
pyruvate, [La+],
and pH
• Maximal average
power was
performance
criterion

• Work in bout 3 ↓
to 82% of work
from bout 2 while
glycogenolysis in
bout 3 was 32% of
bout 2
• Glycogen
phosphorylase
possibly
downregulated by
H+ accumulation
in bout 3

• One-legged
quadricepsspecific supine
ergometer
exercise for 10
minutes at 10 W
• 33 minutes rest
(C) or intense
arm exercise
(HL)
• Exhaustive kneeextensor exercise
with
experimental leg
• Arm exercise
used to elevate
blood
[La+] levels
before
exhaustive
kicking exercise
• Bx pre and post
for each
condition

• Kick frequency
> 55 rpm was
performance
criterion
• Blood flow
measured via
thermodilution and
analyzed for O2
saturation, Hb
concentration, Hct,
and plasma K+
• Bx analyzed for
[La+], glycogen,
and CP

• HL ↓ duration of
exercise
• ↔ Muscle [La+]
concentration and
rate of
accumulation after
exercise in both
conditions
• ↑ muscle H+
concentration after
exercise in HL
• Muscle fatigue
occurred at ↓ pH
but ↔ femoral
blood K+ content
in HL condition
• ↓ pH ↔ rates of
glycogen
breakdown or
[La+] production
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Table 2.3: The Impact of pH and Lactate on Cycling, Leg Kicking, and
Isometric Exercise in Man (continued)
Author/
Year

Subjects

Design

Analyses

Hargreaves
1998 (36)

6 male
subjects

• 3 30-second maximal
cycling bouts, 4
minute passive
recovery between, 30
minutes exercise at
30-35% peak oxygen
consumption and 60
minutes rest prior to
bout 4
• Bx pre-exercise and
after third and fourth
bouts,BS throughout

• BS analyzed for
Hb
concentration,
Hct, plasma H+,
[La+], and K+
• Bx analyzed for
peak SR Ca2+
uptake, pH, and
metabolites

Bout 3 and 4
performance ↓

• Work Capacity Event:
2 trials 3 days apart
• Ingest sodium citrate
(E) or lactose (C) and
exercise at 120%
Wmax until exhaustion
• BS post exercise
• Standardized Event:
Same as above except
fixed-time so work
rate and duration are
controlled
• VL Bx pre and post
• BS post-exercise

• BS analyzed for
[La+] and pH
• Bx analyzed for
[La+], pH, fiber
type, MCT1,
MCT4, NHE1
isoform, and
membranebound carbonic
anhydrase
isoforms
• TTE was the
performance
criterion in
work capacity
event

• Performance and
work capacity
closely related
to
concentrations
of pH/[La+]
regulating
proteins (MCT1,
MCT4, NHE1,
and carbonic
anhydrase)
• Those who
benefitted most
in E condition
were those with
↑ content of
pH/
[La+] regulating
proteins

Messonnier
2007 (70)

3 healthy
sedentary
women
and 5 men

Findings

not result of ↓
muscle glycogen
but ↓ CP
availability, ↑ H+
concentration, or
impairment of SR
function
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Table 2.3: The Impact of pH and Lactate on Cycling, Leg Kicking, and
Isometric Exercise in Man (continued)
Author/Year

Subjects

Design

Analyses

Findings

Iaia 2010 (46)

7 healthy
males

• Exhaustive cycle
exercise preceded
by a warm-up, very
high (30 seconds),
high (3 minutes),
and low (2 hours)
intensity cycling
• Post 2 minutes
recovery, subjects
rode to exhaustion
at 130% VO2max
• BS pre, during, and
post exercise
• VL Bx before and
after both
exhaustive bouts

• BS analyzed
for plasma
ammonia,
glucose, [La+],
and FFA
• Bx analyzed
for lactate, CP,
glycogen, and
pH

Muscle
glycogen and pH
do not control
but affect the
rate of
glycogenolysis/
glycolysis and
fatigue during
high intensity
exercise lasting
less than 2
minutes

s = Seconds, REC = Recovery, BS = Blood Sample, Bx = Biopsy, EG = Expired
Gasses, VL = Vastus Lateralis, [La+] = Lactate concentration, ATP = Adenosine
Triphophate, ADP = Adenosine Monophosphate, AMP = Adenosine
Monophosphate, CP = Creatine Phosphate, HCO3 = Bicarbonate, F-6-P =
Fructose-6-Phosphate, G-6-P = Glucose-6-Phosphate, G-1-P = Glucose-6Phosphate, H+ = Hydrogen, MVC = Maximal Voluntary Contraction, F-1,6-P2 =
Fructose-1,6-Biphosphate, Glyc-3-P = Glycerol-3-Phosphate, K+ = Postassium
HR = Heart Rate, MCT1 = Monocarboxylate Transporter 1, MCT4 =
Monocoarboxylate Transporter 4, NHE1 = Na/H+ Exchanger 1, FFA = Free Fatty
Acid, 2,3-DPG = 2,3-Diphosphoglycerate, TTE = Time to Exhaustion, ↑ =
Increase, ↓ = Decrease, ↔ = No Change

30

Sodium Bicarbonate/Citrate Supplementation and Cycling Performance
The independent effects of sodium bicarbonate and citrate
supplementation on cycling exercise of various durations and intensities are welldocumented. A number of studies have shown that both bicarbonate and citrate
improve performance during high-intensity, short duration, interval type cycling
(11, 18, 47, 60, 62, 66, 67, 69, 77), aerobic cycling (≥ 30 minutes) (68, 72, 92),
and intermittent cycling (81). However, the literature is not unanimous as others
have shown no benefits of supplementation during high-intensity (44, 51, 54, 94,
99) and long-duration cycling (86, 91).
Bicarbonate is a prominent extracellular buffer in the blood and ingesting
either sodium bicarbonate or citrate elevates blood bicarbonate levels. Bishop et
al. suggests that improved performance with bicarbonate supplementation is likely
the result of increased extracellular buffering causing greater efflux of hydrogen
from muscle to blood (11). Since intracellular hydrogen is suspected to play a
role in muscle fatigue, this efflux of hydrogen would be beneficial during intense
anaerobic exercise. McNaughton et al. also illustrated that sodium bicarbonate
supplementation during intense aerobic cycling of one hour yielded a performance
benefit, citing an alteration in extracellular buffering capacity similar to Bishop et
al.’s postulation (68). Despite its impact on blood and muscle pH (18, 86, 91, 99),
blood and muscle lactate (42, 92), as well as performance (11, 47, 60, 66, 67, 72,
77), bicarbonate is not generally used as an ergogenic aid because of gastric
discomfort often resulting in urgent diarrhea (35, 91) or possible lightheadedness
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(54). However, the fact that cycling performance is improved by altering blood
and muscle pH via artificial augmentation of buffering capacity provides
compelling evidence that pH has a role in muscular fatigue during heavy exercise.
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Table 2.4: Bicarbonate/Citrate Supplementation and Cycling Performance
Author/
Year

Subjects

Design

Analyses/
Performance
Criterion

Findings

Sutton
1981 (92)

5 males

• 3 trials: placebo,
NH4CL (acidosis),
or NaHCO3
(alkalosis)
• Cycle for 20 minutes
at 33% VO2max, 20
minutes at 66%
VO2max, then 95%
VO2max to
exhaustion
• Exercise BS and EG

TTE was
performance
criterion

• Endurance longest
in alkalotic
condition and
shortest in acidotic
condition
• [La+] ↑ most from
rest to exhaustion
with alkalosis and
least with acidosis
• Plasma [La+] least
with acidosis
implying inhibition
of glycolysis and ↓
[La+] efflux

Inbar
1983 (47)

13 males

• 2 Trials: 10 grams
NaHCO3 or placebo
• 6 minutes cycling,
4-6 second sprints at
400 watts every 2
minutes, 30 seconds
all-out at 4.41 J/
pedal revolution/kg
• BS pre and post
exercise
• VL Bx pre-exercise

• BS analyzed
for pH and [La
+], fiber type
• Mean and peak
power output
were the
performance
criterion

• Mean power output
significantly ↑ with
NaHCO3
• ↔ Peak power
output
• No relationship
between fiber type
distribution and
NaHCO3 sensitivity

Costill
1984 (18)

2 men and
1 woman

• NaHCO3 (E) or NaCl
(C) an hour before
cycling
• 4 1-minute bouts,
ride to exhaustion at
100% VO2max
• BS and EG
throughout exercise
and recovery
• BL Bx before
ingestion, first bout,
and final bout

• BS analyzed
for lactic acid,
pH, PCO2, and
blood HCO3
• Bx analyzed
for lactic acid
and pH
• TTE in final
bout was
performance
criterion

• During and
following exercise,
blood pH and HCO3
↑ with E
• NaHCO3 ↑
Performance
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Table 2.4: Bicarbonate/Citrate Supplementation and Cycling Performance
(continued)
Author/Year

Subjects

Design

Analyses/
Performance
Criterion

Findings

Katz 1984 (51)

8 males

• 3 trials: 0.2 g/kg
NaHCO3 or
placebo
• Ride to
exhaustion at
125% VO2max
• BS pre, during,
and post exercise
• Recovery EG

• BS analyzed
for [La+], pH,
and pCO2
• TTE was the
performance
criterion

• [La+] efflux ↑
with bicarbonate
ingestion
• NaHCO3 ↔
performance but
may benefit
following repeated
work bouts

Wijnen 1984
(99)

4 welltrained
males

• 4 conditions:
Injection of
either 0.18, 0.36
g/kg NaHCO3 or
placebo
• 4 1-minute bouts
at 125% VO2max
separated by 1
minute rest and a
fifth bout to
exhaustion
• BS pre, during,
and post exercise
• Exercise EG

• BS analyzed
for pH, base
excess, HCO3,
and [La+]
• TTE was
performance
criterion

• ↑ pH proportional

McKenzie 1986
(66)

6 males

• 3 Conditions:
placebo, 0.15, or
0.30 g/kg of
NaHCO3
• 5 bouts of 60
seconds at 125%
VO2max and a
sixth bout to
exhaustion
• BS pre exercise

• BS analyzed
for pH and
HCO3
• Work
production
and TTE were
performance
criterion

• Work in kJ and
TTE significantly
↑ in both
NaHCO3
conditions
• ↔ between
bicarbonate
conditions

Parry-Billings
1986 (77)

6 males

• 4 conditions:
sodium
bicarbonate,
sodium
bicarbonate and
sodium citrate,
sodium citrate,
and placebo
• 3 30 s Wingate
tests separated
by 6 min
recovery
• BS pre, during,
post exercise

• BS analyzed
for pH, [La+],
and PPCO2
• Mean peak
power output
were the
performance
criterion

• Bicarbonate ↑
total work
performed and
performance in
subsequent bouts

to NaHCO3
administration
• Inconclusive
whether NaHCO3
improved
performance
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Table 2.4: Bicarbonate/Citrate Supplementation and Cycling Performance
(continued)
Author/Year

Subjects

Design

Analyses/
Performance
Criterion

Findings

Horswill 1988
(44)

9 endurance
trained male
cyclists

• 4 Trials:
placebo, 0.10 ,
0.15, or 0.20 g/
kg of NaHCO3
• Cycle sprint for
2 minutes
• BS pre and post
ingestion, post
exercise

• BS analyzed for
lactic acid, pH,
PCO2, and PO2
• Total work
output generated
was
performance
criterion

• ↑ in post blood

Lavender and
Bird 1989 (60)

8 females
and 15
males

• 6 trials: 3
placebo and 3
300 mg/kg
NaHCO3
• 10 10-second
cycle sprints
with 50
seconds rest
between

Peak power and
average power
output measured
using lightsensitive monitor
of the flywheel

• NaHCO3 ↑
average power
and peak power
output
• Difference in
average power ↑
as sprint
repetitions ↑

Mitchell 1990
(72)

8 lean men

• 2 Conditions:
HCO3 or
placebo
infusion prior
to exercise
• Ride to
exhaustion at
80% VO2max
• Exercise BS
and EG

• BS analyzed for
[La+], pH, FFA,
glycerol,
alanine, insulin,
norepinephrine,
and epinephrine
• TTE was
performance
criterion

• Endurance ↑
with HCO3
• Plasma glucose ↑
at exhaustion in
control and [La+]
↑ in HCO3
condition
• Performance ↑
not explained by
acid-base change

McNaughton
1991 (67)

8 trained
male
cyclists

• 3 Trials:
control,
placebo, and
CaHCO3
• One minute allout sprint on a
bicycle
ergometer
• BS pre and post

• BS analyzed for
[La+], pH,
HCO3, PPO2,
and PPCO2
• Work performed
in the minute
and peak power
were the
performance
criterion

• CaHCO3 ↑ total
work and
maximal power
output
• Post-exercise Lac
↑ with
bicarbonate

bicarbonate
related to dosing
• This dosing
scheme yielded
↔ performance
during 2 minutes
cycling
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Table 2.4: Bicarbonate/Citrate Supplementation and Cycling Performance
(continued)
Author/
Year

Subjects

Design

Analyses/
Performance
Criterion

Findings

McNaughton
1992 (69)

24 trained
males
separated
evenly into
3 groups

• 3 trials: control,
placebo, or NaHCO3
• 10, 30, 120, or 240
seconds of all-out
cycling
• BS pre and post

• BS analyzed for
PPO2, pH,
HCO3 , and
[La+]
• Total amount of
work and peak
power were the
performance
criterion

• NaHCO3 ↑
blood HCO3
post exercise
but ↔
performance at
10 or 30 s
• At 120 and
240 s,
performance ↑
compared to
control/
placebo

KozakCollins 1994
(54)

7
competitive
female
cyclists

• 2 conditions:
placebo or 300 mg/
kg of NaHCO3
• 1 minute intervals at
95% VO2max until
exhaustion
• BS pre, during, and
post exercise
• Exercise EG

• BS analyzed for
PPO2, PPCO2,
and pH
• Intervals
completed and
total time during
intervals were
performance
criterion

•

Verbitsky
1997 (95)

6 healthy
males

• 3 trials: 3 minutes of
cycling at VO2max,
VO2max + 17%, or
VO2max + 17% and
ingestion of 400 mg/
kg of NaHCO3
• Functional electrical
stimulation test pre
and post exercise to
determine
quadriceps fatigue
• Exercise EG

Peak torque was
performance
criterion

Peak torque ↑
with NaHCO3
ingestion

↔

Intervals
completed and
total time
during
intervals
• NaHCO3 ↔
performance
• NaHCO3
caused
lightheadednes
s in 4 subjects
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Table 2.4: Bicarbonate/Citrate Supplementation and Cycling Performance
(continued)
Author/
Year

Subjects

Design

Analyses/
Performance
Criterion

Findings

3 moderately
active
college-aged
women and 5
men

• 5 trials: VO2peak
test, 2 exhausting
rides at 120%
VO2peak after
sodium citrate or
placebo ingestion,
2 trials at same
relative intensity
as previous trials
minus 20 seconds
• BS throughout all
trials and VL Bx
before 4th and 5th
trials

• BS analyzed for
pH and [La+]
• Bx analyzed for
CP, ATP, G-6-P,
[La+], and
citrate
• TTE was the
performance
criterion.

Sodium citrate
ingestion ↑ TTE
during
supramaximal
exercise but is
not associated
with improved
muscle
metabolic state

McNaughton
1999 (68)

10 trained
male cyclists

• 3 trials: control,
placebo, or
NaHCO3
• 60 minutes
cycling
• BS pre, during and
post exercise

• BS analyzed for
pH, HCO3,
PPO2, PPCO2,
and [La+]
• Amount of
work, peak
power, and
power:mass
ratio were the
performance
criterion

• Amount of
work ↑ in
NaHCO3 trial,
but peak
power and
power:mass
ratio ↔

HollidgeHorvat 2000
(42)

8 healthy
males

• 2 trials separated
by 2-3 weeks: 0.3
g/kg of NaHCO3
or placebo
• 15 minutes at 30,
60, and 75%
VO2max
• BS and EG
throughout
exercise and leg
blood flow
measured via
thermodilution
• 5 VL Bx at rest,
post-ingestion,
and 3 during
exercise

Bx analyzed for
pyruvate
dehydrogenase,
glycogen
phosphorylase
(Phos) activity,
acetyl-CoA, free
CoASH, total
CoA,
acetlycarnitine,
free carnitine,
total carnitine,
ATP, pyruvate,
[La+], CP,
glucose, G-6-P,
G-1-P, F-6-P, and
Gly-3-P. BS
analyzed for O2,
CO2,
[La+], glucose,
FFA, and HCO3

• Induced
alkalosis ↑
glycolysis at
Phos level
relative to
maximal PDH
activation,
creating
discrepancy
between
pyruvate
production and
oxidation
• ↑ [La+]
production

Linossier
1997 (62)
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Table 2.4: Bicarbonate/Citrate Supplementation and Cycling Performance
(continued)
Author/
Year

Subjects

Design

Analyses/
Performance
Criterion

Findings

Schabort
2000 (86)

8 male
cyclists

• 4 trials 3-7
days apart: 40
km time trials
with
interspersed
sprinting
• Placebo and 3
different
sodium citrate
doses (0.2 g/
kg, 0.4 g/kg,
0.6 g/kg)
• Exercise BS

• BS analyzed
for [La+],
glucose, pH,
and PPCO2
• Time to
completion and
sprint
performance
were
performance
criterion

Despite influencing blood
pH, no dosage of sodium
citrate improved time trial
performance, sprint
performance, or average
power output

Stephens
2002 (91)

7
endurance
trained
men

• 2 trials: 0.3 g/
kg NaHCO3 or
placebo
• 30 minutes
cycling at 77
+/- 1%
VO2peak
followed by
~30 min at
~80%
VO2peak
• BS pre, during,
and post
exercise
• Bx pre and
post

• BS analyzed
for pH, gas
partial
pressure, [La
+], Na, K+, and
Cl
• Bx analyzed for
glycogen, [La
+], ATP, CP,
and H+
• Performance
time and
average power
output were
performance
criterion

• NaHCO3 caused small
but significant ↓ in
muscle pH maintained
through exercise
• Induced metabolic
alkalosis ↔ prolonged
cycling performance
• NaHCO3 did not
detriment muscle
glycogen utilization,
muscle [La+]
accumulation, or CP
degradation
• 2 subject defecated
urgently as result of
bicarbonate

Price 2003
(81)

8 healthy
males

• 2 trials:
NaHCO3 or
placebo
• Intermittent
cycling
protocol of 3minute blocks:
90 s at 40%
VO2max, 60 s
at 60%
VO2max, 14 s
maximal
sprint, and 16 s
rest for 30
minutes
• BS pre, during,
and post
exercise

• BS analyzed
for pH and
HCO3
• Peak power
output,
minimum
power output,
mean power
output, and
fatigue index
were
performance
criterion

• ↔ Peak power output
between trials, fatigue
index significantly
different between trials,
and ↑ peak power
output with NaHCO3
• Blood HCO3
concentration ↑ post
exercise with NaHCO3
and pH remained higher
throughout exercise
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Table 2.4: Bicarbonate/Citrate Supplementation and Cycling Performance
(continued)
Author/
Year

Subjects

Design

Analyses/
Performance
Criterion

Findings

Bishop 2004
(11)

10 active
females

• 2 trials: NaHCO3
or placebo
• 5 x 6 s all-out
sprints every 30 s
• BS and EG
throughout
protocol
• Quadriceps Bx
pre and post

• BS analyzed for
[La+] and pH
• Bx analyzed for
[La+], pH, and
buffering
capacity
• 95% of first 6
seconds of 10
second
preliminary test
sprint
performance
was
performance
criterion (kJ)

• NaHCO3 ↑ total

Zoladz 2005
(102)

7 healthy men

• 2 trials: placebo
or 3 mmol/kg of
NaHCO3
• Cycling at 40 or
87% VO2max for
6 minutes
separated by 20
minutes rest
• BS pre, during,
and post exercise
• Exercise EG

BS analyzed for
[La+], pH, HCO3,
blood gasses, Na,
K+, CP, Hb, Hct,
erythrocye, and
leukocyte count

Primary
component of
VO2 kinetics not
altered by
NaHCO3 at low
intensity (40%
VO2max) but was
at high intensity
(87%)

work and ↑
work and power
in sprints 3, 4,
and 5
• ↔ post-test
muscle pH but
NaHCO3
yielded
significantly ↑
[La+]
• ↑ Performance
is likely result
of ↑
extracellular
buffering and
hydrogen efflux
from muscle to
blood
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Table 2.4: Bicarbonate/Citrate Supplementation and Cycling Performance
(continued)
Author/Year

Subjects

Design

Analyses/
Performance
Criterion

Findings

Vanhatalo 2009
(94)

8 active
males

• 2 trials: 0.3 g/
kg of NaHCO3
or placebo
• 3-minutes all
out cycling
with fixed
resistance
halfway
between gas
exchange
threshold and
VO2peak
• Exercise EG
• BS pre, during,
and post
exercise

• BS analyzed for
[La+] changes
• Change in critical
power, or the
boundary between
heavy and severe
exercise associated
with maximal [La
+] steady state,
and the curvature
constant of power
(W’), or anaerobic
work capacity,
were the
performance
criterion

• NaHCO3 ↔
CP, W’, or
overall
performance
despite
enhanced
blood buffer
capacity
• No relationship
between blood
alkalosis and
powerduration
relationship
for all-out
exercise

BS = Blood Sample, EG = Expired Gasses, Bx = Muscle Biopsy, [La+] = Lactate
NH4CL = Ammonium Chloride, NaHCO3 = Sodium Bicarbonate, HCO3 =
Bicarbonate, K+ = Potassium, Na = Sodium, CP = Creatine Phosphate, H+ =
Hydrogen, CL = Chloride, ATP = Adenosine Triphopshate, Hb = Hemoglobin, Hct
= Hematocrit, VL = Vastus Lateralis, TTE = Time to Exhaustion, CaCO3 =
Calcium Bicarbonate, PPO2 = Partial Pressure of Oxygen, PPCO2 = Partial
Pressure of Carbon Dioxide, s = Seconds, ↑ = Increase, ↓ = Decrease, ↔ = No
Change
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Herbal Supplementation, Cycling Performance and Muscle Fatigue
Herbal supplementation to improve exercise performance has become a
popular alternative to bicarbonate and citrate since there are generally less
gastrointestinal ramifications.

The supplement being tested in this study,

SR2W-1, consists of a proprietary blend of the following herbal ingredients:
enoki mushroom, eleuthero extract (Eleutherococcus senticosus), reishi
mushroom, tangerine extract, cordyceps mushroom (Cordyceps sinensis), and
asian ginseng (Panax ginseng). The efficacy of SR2W-1 was evaluated on one
other occasion in cyclists and the results indicated that the supplement decreased
lactic acid accumulation, increased pH, and increased blood bicarbonate during
recovery from intense exercise. However, time to complete a 60,000 Joule time
trial was not affected (57).

No other supplement contains the combined

ingredients in SR2W-1, but some of the individual constituents of the proprietary
blend have been evaluated for potential ergogenic effects during cycling, namely
Eleutherococcus senticosus (eleuthero extract),

Cordyceps sinensis (cordyceps

mushroom), and Panax ginseng (asian ginseng).
Two studies evaluating Eleutherococcus senticosus in cyclists have shown
improved performance. Asano et al. found that supplementation with eleuthero
extract improved VO2max and time to exhaustion. However, glaring limitations in
the experimental design make it difficult to interpret these findings, consequently
limiting generalizability (7). Kuo et al. found similar results to Asano’s study
utilizing a cycling protocol at 75% VO2peak.

The authors also observed elevated
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free fatty acid levels with supplementation (56). In contrast, Eschbach et al.
found that eleuthero supplementation failed to confer any performance or
metabolic advantages during endurance cycling (29). It is important to note that
the loading period of Eschbach’s study was only one week as compared to eight
weeks in Kuo’s study.
Cordyceps sinensis (cordyceps mushroom) is another herb that has
garnered attention as an ergogenic aid for cyclists. The primary claim regarding
cordyceps sinensis is that it improves muscle oxygenation in mice and potentially
in humans. However, the three studies evaluating cordyceps usage in cyclists all
failed to yield gains in performance or any metabolic parameters (15, 23, 76).
A third and most popularly tested constituent of SR2W-1 is asian (panax)
ginseng. While studies involving other modes of exercise have yielded positive
performance results with ginseng supplementation, asian ginseng does not appear
to elicit similar results among cyclists (3, 25-27). Although research involving
elements of SR2W-1 and cycling performance have not been convincing, existing
SR2W-1 research reveals that the combined and synergistic effects of the various
herbals could potentially improve performance.
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Table 2.5 Herbal Supplementation, Cycling Performance and Muscle Fatigue
Author/
Year

Subjects

Design

Analyses/
Performance
Criterion

Findings

Asano 1986
(7)

6 males

• 4 trials: 2 VO2max
tests on consecutive
days was control
• 8 days placebo
supplementation
and VO2max test
then 8 days
Eleutherococcus
senticosus (ES)
supplementation
and VO2max test
• EG during exercise

TTE was
performance
criterion

• ES ↑ VO2max
compared to control
but not placebo.
ES ↑ TTE in all
instances
• Protocol is singleblind. Possible
learning/training
effect

Morris 1996
(73)

7 males
and 1
female

• DB, XO
• 8 mg/kg Panax
Ginseng (PG) and
placebo or 16 mg/
kg and placebo for
seven days
• Ride to exhaustion
at 75% VO2max
• BS pre, during, and
post exercise
• Exercise EG

• BS analyzed
for [La+],
glucose, and
FFA
• TTE was
performance
criterion

↔ TTE with PG

Engels 1997
(27)

36 healthy
men

• R, DB, PC
• Placebo, 200 mg/
day, or 400 mg/day
PG over 8 week
period
• Graded cycling test
starting at 100 watts
and increasing 50
watts every 3
minutes to
exhaustion
• Exercise EG
• BS pre, during, and
post exercise

• BS analyzed
for [La+]
• VO2, RER,
VE, HR, and
RPE were
recorded

↔ physiological or

supplementation

psychological
parameters
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Table 2.5 Herbal Supplementation, Cycling Performance and Muscle Fatigue
(continued)
Author/
Year

Subjects

Allen 1998
(3)

20 men
and 8
women

Design

Analyses/
Performance
Criterion

Findings

•R
• 200 mg PG or placebo
for 3 weeks
• Graded maximal cycling
test to exhaustion
• BS post-exercise
• Exercise EG

• BS analyzed
for [La+]
• Peak aerobic
capacity and
exercise TTE
were
performance
criterion

↔ Peak aerobic
performance and
TTE

Lahr 1999
(57)

12
subjects

• DB, between-groups
design
• Subjects paired based on
[La+] threshold and
assigned to supplement
with 950 mg/day of
herbal formulation
(SR2W-1) or placebo for
5 weeks
• Cycle at [La+] threshold
for 20 minutes, rest for
12 minutes, then
complete 60,000 J TT
• BS pre and post exercise

• BS analyzed
for lactic acid
• TT
performance
was
performance
criterion

• SR2W-1 ↓
lactic acid
accumulation,
↑ pH, and
smaller drop in
HCO3 during
recovery
• TT not
significantly
different but
strong effect
size present

Eschbach
2000 (29)

9 trained
males

• DB, R, XO
• 1200 mg/day of ES or
placebo for 7 days
• 120 minutes at 60%
VO2max followed by 10
km TT
• BS every 20 minutes
during steady state
exercise
• Exercise EG

• BS analyzed
for [La+] and
glucose
• TT
performance
was
performance
criterion

↔ metabolic

Engels 2001
(26)

24 healthy
women

• DB, R
• 400 mg of PG or placebo
for 8 weeks
• 30-second Wingate
cycling test

Peak and mean
anaerobic output
was
performance
criterion

↔ performance

parameters or
performance
with ES
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Table 2.5 Herbal Supplementation, Cycling Performance and Muscle Fatigue
(continued)
Author/
Year

Subjects

Design

Analyses/
Performance
Criterion

Findings

Kiew 2001
(52)

Nine male
cyclists

• DB, XO
• 2 trials: 3 ml/kg of
placebo or Argomas
herbal supplement
• Cycle to exhaustion at
70% VO2max for 90
minutes then 80%
VO2max to exhaustion
• Exercise EG

TTE was the
performance
criterion

↔ TTE or

Earnest 2004
(23)

17
competitive
male
cyclists

• Pre and post 14 day
loading period with
Optygen (primarily
cordyceps sinensis and
rhodiola rosea)
• 4 minute stages starting
at 100 watts, increasing
25 watts until exhaustion
• Exercise EG
• BS pre, during, and post
exercise

• BS analyzed
for [La+]
• TTE and peak
wattage were
the
performance
criterion

↔

Parcell 2004
(76)

22 collegeaged male
cyclists

• 5 weeks of 3.15 g of
CordyMax Cs-4
(cordyceps sinensis) or
placebo
• 1-hour TT at 75% max
wattage calculated from
pre-test
• EG during and after
exercise

TT completion
time was the
performance
criterion

↔ aerobic

Colson 2005
(15)

8 healthy
males age
18-50 years

• DB, R, PC
• 2000 and 1000 mg
cordyceps sinensis and
rhodiola rosea for 6 days
and seven days
respectively or placebo
• Graded test to
exhaustion
• Exercise EG
• Muscle tissue
oxygenation and blood
flow measured via NIRS

TTE was
performance
criterion

↔ VO2max,

metabolic
parameters

performance
or metabolic
parameters

capacity or TT
performance

muscle
oxygenation,
or TTE
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Table 2.5 Herbal Supplementation, Cycling Performance and Muscle Fatigue
(continued)
Author/
Year

Subjects

Design

Analyses/
Performance
Criterion

Findings

Kuo 2009
(56)

9 males

• DB, R, XO
• 800 mg/day of
ES and placebo
for 8 weeks
separated by
four weeks
wash-out
• Cycling at 75%
VO2max until
exhaustion
• BS pre, during,
and post
exercise
• Exercise EG

• BS analyzed for
[La+], FFA,
glutamate
oxaloacetate
transaminase,
glutamate
pyruvate
transaminase,
blood urea
nitrogen, and
creatinine
• TTE was
performance
criterion

↑ VO2peak, TTE, and

Dalbo 2010
(20)

15 active
men

• 3 trials: water,
rice flour
(placebo), or
250 mg of a
mineral
antioxidant
complex
(MAC)
supplement
• VO2peak test
• BS pre, during,
and post
exercise
• Total body
water assessed
pre and post
exercise

• BS analyzed for
[La+]
• VO2peak test
served as the
performance
criterion

• ↔ aerobic exercise

FFA production

performance or
[La+] response
• MAC ↑ total body
water and
intracellular water

ES = Eleutherococcus Senticosus, PG = Panax Ginseng, BS = Blood Sample, EG
= Expired Gasses, TTE = Time to Exhaustion, Lac = Lactate, FFA = Free Fatty
Acid, RER = Respiratory Exchange Ration, VE = Ventilation, HR = Heart Rate,
RPE = Rate of Perceived Exertion, DB = Double-Blind Design, R = Randomized
Design, PC = Placebo-Controlled Design, XO = Cross-Over Design, HCO3 =
Bicarbonate, TT = Time Trial, CS = Cordyceps Sinensis
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Summary
Much attention has been paid to the possible role that acidosis has in
muscular fatigue during high-intensity exercise. Proposed mechanisms include
inhibited calcium release and uptake by the sarcoplasmic reticulum, inhibitions in
calcium binding to troponin C, and functional disruptions of enzymes found in the
glycolytic pathway, all of which could inhibit skeletal muscle function. There is
also evidence that lactate itself could influence calcium dynamics of the
sarcoplasmic reticulum despite lactate being a potential source of fuel during
exercise. At the very least, it is agreed that hydrogen ions and lactate accumulate
during high-intensity exercise and that exercise intensity cannot be maintained for
an extended duration under these conditions.

Supplementing with sodium

bicarbonate and citrate, compounds known to improve buffering capacity directly
in the blood and indirectly in the muscle, improves performance and provides
convincing evidence for the fact that pH management is important for preventing
fatigue. Concentration of the pH/lactate management proteins MCT1 and MCT4
substantiates this since possessing higher levels correlates to improved highintensity exercise performance. Since bicarbonate/citrate supplementation often
causes gastrointestinal problems, herbal supplementation has become popular as
an alternative for altering pH during intense exercise. The current project was
therefore designed to address the efficacy of a multi-ingredient herbal supplement
on high-intensity cycling performance.

CHAPTER THREE
METHODOLOGY
Subjects
Seven male and female recreational cyclists, aged 18-55 were recruited
from James Madison University and the surrounding Harrisonburg area. Subject
characteristics are summarized in Table 3.1. Subjects were provided with written
and verbal information about the experimental procedures, including potential
risks, prior to completing the informed consent (Appendix II). All procedures
were approved by the James Madison University Institutional Review Board prior
to testing.
Table 3.1: Subject Characteristics

Mean ±
SE

Age
Weight
(years)
(kg)

Height
(cm)

VO₂max
(mL/kg/min)

20-min
Ride
Wattage

Interval
Wattage

26.7 ±
9.8

172.5 ±
13.3

59.5 ±
11

212.1 ±
25.0

272.9 ±
26.9

67.1 ±
10.7

Testing Procedures
Cardiorespiratory Fitness (VO₂max)
Subjects performed a graded exercise test to determine peak oxygen
uptake (VO₂max) on a Racermate Velotron (Seattle, WA) cycle ergometer. Initial
workload was subjectively determined during a self-selected 5-minute warm-up.
Subjects selected an intensity maintainable for 90 minutes at an “easy to
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moderate intensity.”

Following the warm-up, workload was incrementally

increased by 20 W every 3 minutes until volitional fatigue or until subjects could
no longer maintain a pedaling cadence ≥ 50 revolutions per minute. VO2, RER,
and VE were continuously monitored with a Sensormedics Spectra metabolic cart
(Yorba Linda, CA). Heart rate throughout each test was monitored using a Polar
heart rate monitor (Lake Success, NY). Blood lactate levels were assessed via
finger stick in the final minute of each exercise stage using a YSI 2300 STAT
glucose/lactate analyzer (Yellow Springs, OH) to determine lactate threshold (≥ 1
mmol/L above resting lactate levels), after which blood sampling was
discontinued. RPE was obtained in the final minute of each exercise stage and the
workload (watts) at max was used to determine workloads during the
familiarization and treatment trials.

Familiarization and Treatment Trials
Each subject performed five trials over the course of nine weeks. The
initial trial was included as a familiarization session with four subsequent trials
serving as the treatment trials (TT).

The general study design is outlined in

Figure 3.1. The four treatment trials were conducted using a randomized, doubleblind, cross-over design. The first two treatment trials occurred before and after
three weeks of supplementation with either placebo or SR2W-1. Following a 14day washout phase, subjects completed two more treatment trials conducted
before and after three weeks of supplementation (placebo or SR2W-1, depending
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on first phase). All trials were performed at ambient temperatures of 21-22°C.
An Essential Home fan, set on ‘medium’ speed, was placed 2 meters from the
handlebars of the cycle ergometer for cooling purposes during trials. Subjects
were instructed to perform each trial as a competitive event.

Figure 3.1: Study Design

A visual representation of the exercise protocol is displayed in Figure 3.2.
Subjects reported to the lab in the morning after a 10-12 hour overnight fast. To
standardize for postural-related hemodynamics, subjects laid down for ten
minutes prior to blood flow measurements.

During that time, an indwelling

catheter was inserted into the arm while their right leg was prepped for the muscle
biopsy (Lidocaine, incision, and bandaging). Resting blood flow was then
assessed by the same investigator using a Shenzen Mindray DC-6 5-10 MHz
duplex ultrasound machine (Shenzen, Nanshan, China).
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Figure 3.2: Treatment Trial Protocol

Following catheter insertion, biopsy preparation, and femoral ultrasound,
subjects performed a 3-minute warm-up at 100 watts, after which the subjects
rode for 20 minutes at a fixed-wattage that elicited 85% of the subject’s VO2max.
Immediately following the 20-minute ride, subjects completed three one-minute
intervals at a workload coinciding with VO2max with 30-seconds of active
recovery at 100 watts between each interval. Following the final interval, subjects
stopped cycling and began a 15-minute passive recovery phase during which the
subject underwent a muscle biopsy (1 minute into recovery) and femoral artery
ultrasound (8 minutes into recovery). Following recovery, subjects cycled at a
workload coinciding with VO2max until fatigued (cadence ≥ 50 RPM).

Exercise Performance
Performance was measured by cycling duration (seconds) during the time
to fatigue portion of the treatment trial.
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Muscle Biopsy
Muscle biopsies were obtained from the vastus lateralis (VL) during the
15-minute recovery period of all treatment trials (10).

The biopsy was taken

within 1 minute of dismounting the ergometer in order to capture the metabolic
state of muscle immediately after exercise.

The muscle sample was quickly

trimmed of excess adipose tissue and frozen in liquid nitrogen in order to halt
metabolism. Each sample was then stored at -80℃ for later analysis of muscle
lactate.

The subjects were re-bandaged in order to complete the ride to

exhaustion.

Muscle Lactate
Muscle samples from each treatment trial were thawed to -20 to -15℃ and
cut into 15-30 mg pieces using a refrigerated scale. Samples were then refrozen
at -80℃, transferred to a glass culture tube containing 0.5 ml 3 M perchloric acid
(PCA) solution, homogenized, diluted with 1 M glycine/hydrazine stock (pH 9.8 10), and stirred with a pestle.

NADH was then measured using a

spectrophotometer at 340 nm. Muscle lactate values were calculated
mathematically based on fluorescence results (17).
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Blood Lactate, pH, and Glucose
Preceding each exercise trial, an indwelling antecubital venous catheter
was inserted by a phlebotomy-trained investigator. During exercise, the catheter
was flushed periodically with an injectible saline solution to prevent coagulation.
Blood samples were obtained at the following time points: minutes 10 and 20
during the 20-minute fixed intensity ride, after the second high-intensity interval,
and minutes 1.5, 3, 6, 9, 12, and 15 of recovery. Glucose and lactate levels were
measured immediately from whole blood using a YSI 2300 STAT glucose/lactate
analyzer (Yellow Springs, Ohio).

VO2, RER, and Ventilation
VO2, RER, and Ventilation were assessed at minutes 10 and 20 during the
fixed-intensity ride and after the second high-intensity interval. A SensorMedics
Spectra (Yorba Linda, CA) metabolic cart was used to monitor breath-by-breath
gas exchange and average respiratory data over thirty seconds.

Heart Rate
Heart rate was recorded at minutes 10 and 20 during the fixed intensity
ride, after the second high-intensity interval, and at minutes 3, 6, 9, and 12 during
the recovery phase using a Polar heart rate monitor (Lake Success, NY).
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Ratings of Perceived Exertion (RPE)
Subjective ratings of exertion were obtained by having the subject point to
a corresponding exertion level on a Borg RPE scale (numerically rated from
6-20). RPE was obtained at minutes 10 and 20 of the fixed intensity ride and after
the second high-intensity interval.

Blood Flow
Left femoral artery peak velocity and diameter were measured 5-7 mm
below the inguinal crease using a Mindray DC-6 (Nanshan, Shenzen, China) 5-10
MHz duplex ultrasound machine. Blood flow was calculated using the equation:
∏r²

(mm) x peak velocity (cm/s) x 60 seconds. Pre-exercise peak velocity and

diameter was assessed at rest and post-exercise measurements were obtained eight
minutes following the completion of the high-intensity intervals.

Supplement
Subjects were randomly assigned to receive either 1000 mg/day of
SR2W-1 or 1000 mg/day of placebo.

Subjects ingested 2 x 500 mg capsules

every morning for 21 days during the supplementation periods.

To promote

supplementation compliance, subjects were required to text, e-mail, or call a
member of the investigative team immediately after supplementation. SR2W-1 is
a proprietary blend of herbs and fungi (primary ingredients: Enoki mushroom,
Eleuthero extract, Reishi mushroom, tangerine extract, Cordyceps mushroom, and
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Asian Ginseng). The placebo was provided by Radix BioResearch and was in
capsule form identical to SR2W-1.

Dietary and Exercise Controls
Throughout the duration of the study, subjects were instructed to: 1.
maintain consistent dietary habits for 72 hours prior to each trial, 2. complete a
diet record (Appendix V) for the 24 hours preceding each trial, 3. avoid heavy
exercise for 48 hours prior to each trial, 4. maintain consistent physical activity
habits starting 72 hours prior to the first treatment trial until the completion of the
final treatment trial (~55 days), and 5. Record all physical activity performed
during the 24 hours preceding each trial (Appendix VI). Subjects consumed their
final ‘self-selected’ meal no less than 10 hours prior to the start of treatment trials
(i.e. dinner on the evening prior to testing) and were allowed to consume only
water ad libitum until the end of each treatment trial (total of ~10-12 hours of
fasting with water intake).

Statistical Analyses
Due to the small sample size in this study, the Wilcoxon Signed Rank test
was applied to compare change scores from pre- to post- supplementation (EXP
vs. PLA for each dependent variable). More specifically, differences between preand post-supplementation cycling time to fatigue, muscle lactate, blood lactate,
blood glucose, VO2, RER, VE, HR, and skeletal muscle blood flow were
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compared between treatments at a given time point during exercise and recovery.
Significance was set at p < 0.05. All blood lactate data during recovery was
analyzed using differences in area underneath a curve. Results are reported as
means ± SE.

CHAPTER FOUR
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ABSTRACT
Purpose: The purpose of this investigation was to examine the effects of SR2W-1
herbal supplementation on cycling performance, muscle and blood lactate, and
various physiological parameters including blood glucose, heart rate (HR), rating
of perceived exertion (RPE), oxygen consumption (VO2), expired ventilation
(VE), respiratory exchange ratio (RER), and femoral artery blood flow. Methods:
Seven recreational cyclists (Age: 26.7 ± 9.8 yrs, Height: 172.5 ± 13.3 cm, Weight:
67.1 ± 10.7 kg, and VO2max: 59.5 ± 11 mL/kg/min) performed 20-min of steadystate cycling (~85% VO2max, 212.1 ± 25.0 W) followed by three 1-min high
intensity intervals at VO2max workload (272.9 ± 26.9) with 30-sec active recovery
periods at 100 watts.

Following intervals, a 15-min passive recovery period

preceded a ride to fatigue at VO2max workload. Subjects completed trials on four
occasions; preceding and following 21 days of 1000mg/d SR2W-1 (EXP) and
1000mg/d placebo (PLA) assigned in random order. The Wilcoxon Signed-Rank
Test was used to compare change-scores from pre- to post- PLA and EXP
conditions.

Results: No differences reported for any dependent variable and

performance times were not different between PLA (pre-PLA: 180 ± 48 s; postPLA: 198 ± 56 s) and EXP (pre-EXP: 170 ± 57 s; post-EXP: 191 ± 50 s).
Conclusion: Notwithstanding the small sample size, 3 weeks of SR2W-1
supplementation does not appear to aid cycling performance, attenuate skeletal
muscle fatigue, or modify general physiological responses to exercise.
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INTRODUCTION
High levels of blood lactate and concomitant reductions in pH are strongly
associated with the onset of fatigue. In 1907, Fletcher and Hopkins examined
lactic acid levels in working frog muscles and stated that “an acid reaction of the
muscle is, as most agree, a constant mark of the fatigued condition and a constant
condition of the state of rigor,” providing evidence that acidity has been
associated with decreased function and fatigue for over a century (33).

The

precise role that lactic acid plays in muscular fatigue has been debated, partially
as a result of the lack of supporting evidence regarding lactic acid’s proton
contribution and the positive energetic properties of lactate.

However, the

deleterious effects that hydrogen ions have on skeletal muscle function are welldocumented.

In-vitro skeletal muscle experiments have shown that low intra-

muscular pH can interfere with several reactions within the muscle cell, inhibiting
function and causing fatigue (13, 30, 59).

It has also been suggested that

hydrogen ion accumulation may inhibit the release of calcium from the
sarcoplasmic reticulum and interfere with the transmission of neural impulses
which can also decrease function (45). Although there are other potential sources
of muscular fatigue such as fatigue of the central nervous system, psychological
factors, and inorganic phosphate accumulation in the muscle cell, acidosis is often
regarded as the most prevalent source of fatigue during intense exercise.
Since intense exercise is associated with a drop in pH and inevitable
fatigue, athletes can benefit from strategies that mitigate the acidifying effect of
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exercise to enhance their performance.

In 1924, A.V. Hill acknowledged the

importance of tissue and blood buffers and their effect on muscular effort (39).
As early as the 1930’s, researchers experimented with induced alkalosis and its
effect on performance. They hypothesized that by increasing blood alkalinity,
more lactic acid could be produced implying more energy from anaerobic
glycolysis and achievement of higher intensities (64). After being largely ignored
for nearly 30 years due to initial null findings, a resurgence of research in the
1970‘s began to indicate that manipulating extracellular buffering capacity can
impact intracellular pH. Bicarbonate supplementation became the predominant
mode of inducing blood alkalinity since the bicarbonate buffer system is a
primary source of blood’s buffering capacity.

Research shows that increasing

blood pH with bicarbonate increases the rate of lactate and hydrogen efflux from
muscle cells despite the relative impermeability of the sarcolemma to bicarbonate
(18, 43, 48, 88, 92). This suggests that hydrogen ion efflux from the cell works
down a concentration gradient. Conceptually, an increased concentration gradient
facilitated by changes in extracellular lactate/H+ should allow for more lactate/H+
transport from the active skeletal muscle, thereby delaying fatigue. As a result,
lactate/H+ supplement research has become prevalent due to its potential
performance-enhancing benefits.
SR2W-1 is a commercially available herbal supplement designed to
improve high-intensity exercise performance.

Preliminary research on the

efficacy of SR2W-1 is promising as two investigations have demonstrated that
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SR2W-1 prolongs exercise endurance, promotes lactate clearance after
exhaustive exercise, and improves overall performance (1, 57).

Additionally,

some research involving the constituents of SR2W-1 have yielded performance
benefits during cycling (7, 56). However, the two existing SR2W-1 studies were
not peer reviewed and possessed major methodological limitations.

Thus, the

primary aims of the current study were to evaluate the effect of the herbal
supplement SR2W-1 on high-intensity cycling performance as well as blood and
skeletal muscle lactate metabolism. Blood glucose, VO2, RER, VE, HR, RPE, and
femoral artery blood flow were also observed to further elucidate the effects of the
supplement.

We hypothesized that SR2W-1 supplementation would improve

cycling performance, reduce blood lactate levels during varying intensities of
cycling exercise and during exercise recovery, reduce skeletal muscle lactate
levels, and increase blood flow during recovery.

METHODS
Subjects
Seven male and female recreational cyclists, aged 18-55 were recruited
from James Madison University and the surrounding Harrisonburg area. Subject
characteristics are summarized in Table 3.1. Subjects were provided with written
and verbal information about the experimental procedures, including potential
risks, prior to completing the informed consent (Appendix II). All procedures
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were approved by the James Madison University Institutional Review Board prior
to testing.

Table 4.1: Subject Characteristics

Mean ±
SE

Age
(years)

Weight
(kg)

Height
(cm)

VO₂max
(mL/kg/min)

20-min
Ride
Wattage

Interval
Wattage

26.7 ±
9.8

67.1 ±
10.7

172.5 ±
13.3

59.5 ±
11

212.1 ±
25.0

272.9 ±
26.9

Testing Procedures
Cardiorespiratory Fitness (VO₂max)
Subjects performed a graded exercise test to determine peak oxygen
uptake (VO₂max) on a Velotron Racermate (Seattle, WA) cycle ergometer. Initial
wattage was subjectively determined during a self-selected 5-minute warm-up.
Subjects selected an intensity that could be maintained for 90 minutes at “easy to
moderate intensity.” Following warm-up, workload was incrementally increased
by 20 W every 3 minutes until volitional fatigue or until subjects could not longer
maintain a pedaling cadence ≥ 50 revolutions per minute. VO2, RER, and VE
were continuously monitored with a Sensormedics Spectra (Yorba Linda, CA)
metabolic cart. Heart rate was monitored throughout each test using a Polar heart
rate monitor (Lake Success, NY). Blood lactate levels were assessed in the final
minute of each exercise stage using a YSI 2300 STAT glucose/lactate analyzer
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(Yellow Springs, OH) to determine lactate threshold, after which blood sampling
was discontinued. RPE was obtained in the final minute of each exercise stage
and wattage at VO₂max was used to determine workloads during the
familiarization and treatment trials.

Familiarization and Treatment Trials
Each subject performed five trials over the course of nine weeks. The
preliminary trial served as a familiarization trial while the remaining four trials
were the treatment trials (TT). The general study design is outlined in Figure 3.1.
The four treatment trials were conducted using a randomized, double-blind, crossover design and the two three-week supplementation phases were separated by a
14-day washout period. The first two treatment trials occurred before and after
three weeks of supplementation with either placebo or SR2W-1. Following the
washout phase, subjects completed two more treatment trials conducted before
and after three weeks of supplementation (placebo or SR2W-1, depending on first
phase).

All trials were performed at ambient temperatures of 21-22°C.

An

oscillating fan, set on ‘medium’ speed, was placed 2 meters from the handlebars
of the cycle ergometer for cooling purposes during trials.
instructed to perform each trial as a competitive event.

Subjects were
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Figure 4.1: Study Design

A visual representation of the exercise protocol is displayed in Figure 3.2.
Subjects reported to the lab in the morning after a 10-12 hour overnight fast. To
standardize for posture-related hemodynamics, subjects laid down for ten minutes
prior to blood flow measurements. During that time, an indwelling catheter was
inserted into the arm while their right leg was prepared for a muscle biopsy
(Lidocaine, incision, and bandaging). Resting blood flow was then assessed by the
same investigator using a Shenzen Mindray DC-6 (Shenzen, Nanshan, China)
5-10 MHz duplex ultrasound machine.
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Figure 4.2: Treatment Trial Protocol

Following catheter insertion, biopsy preparation, and femoral ultrasound,
subjects performed a 3-minute warm-up at 100 watts, after which the subjects
rode for 20 minutes at a fixed-wattage that elicited 85% of the subject’s VO2max.
Immediately following the 20-minute ride, subjects completed three one-minute
intervals at 100% of wattage at VO2max with 30-seconds of active recovery at 100
watts between each interval.

Following the final interval, subjects stopped

cycling and began a 15-minute recovery phase during which the subject
underwent a muscle biopsy (1 minute into recovery) and femoral artery
ultrasound (8 minutes into recovery).

Following recovery, subjects cycled at

100% wattage at VO2max until volitional fatigue (cadence ≥ 50 RPM).

Exercise Performance
Performance was measured by cycling duration (seconds) during the time
to fatigue portion of the treatment trial.
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Muscle Biopsy
Muscle biopsies were obtained from the VL during the 15-minute recovery
period of all treatment trials (10).

The biopsy was taken within 1 minute of

dismounting the ergometer in order to capture the metabolic state of muscle
immediately after exercise. The muscle sample was quickly trimmed of excess
adipose tissue and frozen in liquid nitrogen in order to halt metabolism. Each
sample was then stored at -80℃ for later analysis of muscle lactate. The subject
was re-bandaged in order to complete the ride to exhaustion.

Muscle Lactate
Muscle samples from each treatment trial were thawed to -20 to -15℃ and
cut into 15-30 mg pieces using a refrigerated scale. Samples were then frozen
again to -80℃, transferred to a glass culture tube containing 0.5 ml 3 M
perchloric acid (PCA) solution, homogenized, diluted with 1 M glycine/hydrazine
stock (pH 9.8 - 10), and homogenized again. NADH was then measured using a
spectrophotometer at 340 nm.

Muscle lactate values were calculated

mathematically based on fluorescence results (17).

Blood Lactate, pH, and Glucose
Preceding each exercise trial, an indwelling antecubital venous catheter
was inserted by a phlebotomy-trained investigator. During exercise, the catheter
was flushed periodically with an injectible saline solution to prevent coagulation.
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Blood samples were obtained at the following time points: minutes 10 and 20 of
the 20-minute fixed intensity ride, immediately following the second highintensity interval, and minutes 1.5, 3, 6, 9, 12, and 15 of recovery. Glucose and
lactate levels were measured immediately from whole blood using a YSI 2300
STAT glucose/lactate analyzer (Yellow Springs, Ohio).

VO2, RER, and Ventilation
VO2, RER, and Ventilation were assessed at minutes 10 and 20 during the
fixed-intensity ride and after the second high-intensity interval. A SensorMedics
Spectra (Yorba Linda, CA) metabolic cart was used to monitor breath-by-breath
gas exchange and average respiratory data over thirty seconds.

Heart Rate
Heart rate was recorded at minutes 10 and 20 during the fixed intensity
ride, after the second high-intensity interval, and at minutes 3, 6, 9, and 12 during
the recovery phase using a Polar heart rate monitor (Lake Success, NY).

Ratings of Perceived Exertion (RPE)
Subjective ratings of exertion were obtained by having the subject point to
the corresponding exertion level on a Borg RPE scale (numerically rated from
6-20). RPE was obtained at minutes 10 and 2 of the fixed intensity ride and after
the second high-intensity interval.
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Blood Flow
Left femoral artery peak velocity and diameter was measured 5-7 mm
below the inguinal crease using a Mindray DC-6 (Nanshan, Shenzen, China) 5-10
MHz duplex ultrasound machine. Blood flow was calculated using the equation:
∏r²

(mm) x peak velocity (cm/s) x 60 seconds. Pre-exercise peak velocity and

diameter was assessed at rest and post-exercise measurements were obtained eight
minutes following the completion of the high-intensity intervals.

Supplement
Subjects received either 1000 mg/day of SR2W-1 and 1000 mg/day of
placebo in randomly assigned order. Subjects ingested 2 x 500 mg capsules every
morning for 21 days during the supplementation periods.

To promote

supplementation compliance, subjects were required to text, e-mail, or call a
member of the investigative team immediately after supplementation. SR2W-1 is
a proprietary blend of herbs and fungi (primary ingredients: Enoki mushroom,
Eleuthero extract, Reishi mushroom, tangerine extract, Cordyceps mushroom, and
Asian Ginseng). The placebo was provided by Radix BioResearch and was in
capsule form identical to SR2W-1.
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Dietary and Exercise Controls
Throughout the duration of the study, subjects were instructed to: 1.
Maintain consistent dietary habits for 72 hours prior to each trial, 2. Complete a
diet record (Appendix V) for the 24 hours preceding each trial, 3. Avoid heavy
exercise for 48 hours prior to each trial, 4. Maintain consistent physical activity
habits starting 72 hours prior to the first treatment trial until the completion of the
final treatment trial (~55 days), and 5. Record all physical activity performed
during the 24 hours preceding each trial (Appendix VI). Subjects consumed their
final ‘self-selected’ meal no less than 10 hours prior to the start of treatment trials
(i.e. dinner on the evening prior to testing) and were allowed to consume only
water ad libitum until the end of each treatment trial (total of ~10-12 hours of
fasting with water intake).

Statistical Analyses
Due to the small sample size in this study, data was analyzed with
Wilcoxon Signed Rank tests utilizing change scores for each dependent variable
from pre- to post- supplementation under EXP and PLA conditions. Specifically,
differences between pre- and post-supplementation cycling time to fatigue,
muscle lactate, blood lactate, blood glucose, VO2, RER, VE, HR, and skeletal
muscle blood flow were compared between treatments at a given time point
during exercise. Significance was set at p < 0.05. All blood lactate data
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during recovery was analyzed using differences in area underneath the curve.
Results are reported as means ± SE.

RESULTS
Exercise Performance
!

Time to fatigue was not differentially impacted by PLA and EXP

supplementation . Individual performance times are displayed in Figure 4.3 (prePLA: 180 ± 48 sec; post-PLA: 198 ± 56; pre-EXP: 170 ± 57; post-EXP: 191 ±
50).

Skeletal Muscle Lactate
PLA and EXP supplementation did not differentially affect skeletal muscle
lactate levels during recovery. Muscle lactate levels are displayed in Figure 4.4
(pre-PLA: 13.8 ± 2.4 mmol/kg wet wt; post-PLA: 13.0 ± 2.1; pre-EXP: 14.3 ±
2.0 ; post-EXP: 12.8 ± 2.2).

Blood Lactate and Glucose
Blood lactate and glucose levels were not differentially impacted by PLA
and EXP supplementation.
Table 4.2.

Blood lactate and glucose levels are displayed in

Performance Time (seconds)
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1

2

pre PLA

Figure 4.3 Exercise Performance

3
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pre EXP

Subject Number

post PLA

5

6

post EXP

7
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Lactate (mmol/kg wet wt)
0

4

8

12

16

20

Pre-PLA

Figure 4.4 Skeletal Muscle Lactate

Post-PLA

Pre-EXP

Post-EXP
72
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Table 4.2 Blood Glucose and Lactate Levels Before and After
Supplementation
Placebo
Time (min)

Experimental

Variable

Pre

Post

Pre

Post

Glucose (mg/dL)

75.9 ± 4.0

72.0 ± 3.2

76.7 ± 3.3

71.5± 3.1

Lactate (mmol/L)

3.0 ± 0.5

2.7 ± 0.3

3.2 ± 0.3

3.1 ± 0.5

Glucose (mg/dL)

80.1 ± 4.1

75.2 ± 3.2

82.2 ± 3.2

76.9 ± 2.4

Lactate (mmol/L)

3.5 ± 0.6

3.2 ± 0.5

3.7 ± 0.3

3.6 ± 0.5

Glucose (mg/dL)

83.0 ± 4.1

77.5 ± 2.5

86.0 ± 3.2

80.9 ± 2.6

Lactate (mmol/L)

4.7± 0.7

4.3 ± 0.6

5.0 ± 0.4

4.6 ± 0.6

10

20

22:30
15-min recovery
Lactate (mmol/L) 56.7 ± 12.6 55.1 ± 11.3 60.5 ± 8.2
AUC

AUC = Area Under the Curve

57.0 ± 12.7
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VO2, RER, and Ventilation
PLA and EXP supplementation did not differentially impact VO2 (ml/min
and mL/kg/min), RER, or VE (L/min). VO2, RER, and VE are displayed in Table
4.3.

Table 4.3 VO2, RER, and VE Before and After Supplementation
Placebo
Time (min)

Experimental

Variable

Pre

Post

Pre

Post

VO2 (L/min)

3.4 ± 0.4

3.4 ± 0.3

3.5 ± 0.3

3.4 ± 0.3

VO2 (ml/kg/min) 49.0 ± 3.5

50.7 ± 3.1

51.2 ± 3.8

50.6 ± 4.0

10

20

22:30

RER

0.91 ± 0.01

0.92 ± 0.01

0.91 ± 0.01

0.93 ± 0.02

VE (L/min)

85 ± 7

87 ± 6

91 ± 8

92 ± 8

VO2 (L/min)

3.4 ± 0.3

3.5 ± 0.3

3.5 ± 0.3

3.4 ± 0.3

VO2 (ml/kg/min) 49.6 ± 3.3

51.1 ± 2.9

51.2 ± 3.4

50.5 ± 3.4

RER

0.89 ± 0.01

0.89 ± 0.02

0.91 ± 0.01

0.89 ± 0.01

VE (L/min)

89 ± 6

91 ± 6

99 ± 8

93 ± 6

VO2 (L/min)

3.5 ± 0.3

3.6 ± 0.3

3.4 ± 0.4

3.5 ± 0.3

VO2 (ml/kg/min) 51.1 ± 2.1

53.0 ± 2.2

52.3 ± 2.8

52.2 ± 2.8

RER

0.99 ± 0.02

0.97 ± 0.03

0.97 ± 0.02

0.97 ± 0.03

VE (L/min)

107 ± 6

109 ± 7

117 ± 6

112 ± 6
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Heart Rate and Ratings of Perceived Exertion
Heart rate and RPE numbers were not differentially impacted by PLA and
EXP supplementation. HR and RPE are displayed in Table 4.4.

Table 4.4 Heart Rate and RPE Before and After Supplementation
Placebo
Time (min)

Experimental

Variable

Pre

Post

Pre

Post

HR (bpm)

171 ± 5

169 ± 4

173 ± 5

172 ± 6

RPE

14.9 ± 0.3

14.1 ± 0.5

14.9 ± 0.5

14.8 ± 0.6

HR (bpm)

175 ± 4

173 ± 4

177 ± 5

177 ± 5

RPE

16.7 ± 0.6

15.9 ± 0.5

16.4 ± 0.4

16.1 ± 0.7

HR (bpm)

184 ± 4

182 ± 4

185 ± 4

183 ± 5

RPE

18.3 ± 0.5

17.7 ± 0.6

17.7 ± 0.7

17.9 ± 0.7

3R

HR (bpm)

100 ± 6

104 ± 6

107 ± 5

104 ± 5

6R

HR (bpm)

96 ± 7

97 ± 4

98 ± 5

98 ± 4

9R

HR (bpm)

95 ± 4

92 ± 4

95 ± 4

98 ± 6

12R

HR (bpm)

91 ± 6

89 ± 4

93 ± 5

91 ± 5

10

20

22:30

R = Recovery
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Blood Flow
Blood flow (L/min) was not differentially impacted by PLA and EXP
supplementation . Blood flow is displayed in Table 4.5.

Table 4.5 Blood Flow (L/min)
PLA

EXP

Pre Exercise

8-minute Post
Exercise

Pre Exercise

8-minute Post
Exercise

Pre
Supplementation

1.1 ± 0.1

1.6 ± 0.1

1.1 ± 0.1

1.5 ± 0.2

Post
Supplementation

1.2 ± 0.1

1.5 ± 0.2

1.2 ± 0.1

1.7 ± 0.1
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DISCUSSION
The primary aims of this study were to evaluate the effect of the herbal
supplement SR2W-1 on high-intensity cycling performance as well as blood and
skeletal muscle lactate metabolism. Blood glucose, VO2, RER, VE, HR, RPE, and
femoral artery blood flow were also observed to further elucidate the effects of the
supplement.

We hypothesized that SR2W-1 supplementation would prolong

cycling time to fatigue, reduce blood lactate levels during varying intensities of
cycling exercise and during exercise recovery, and reduce skeletal muscle lactate
levels and increase blood flow during recovery. Contrary to our hypotheses, the
collective results indicate that SR2W-1 does not affect time to fatigue, blood or
muscle lactate levels, or any of the aforementioned physiological parameters.
Therefore, SR2W-1 supplementation does not appear to be an effective ergogenic
stategy, at least in the context of high-intensity cycling.
Despite some evidence supporting the efficacy of herbal supplementation
(7, 56, 57), the performance findings in this study are consistent with the larger
body of literature.

Only one study has evaluated the impact SR2W-1

supplementation on cycling performance, which reported that 60,000 Joule time
trial performance was unchanged (57). It is worth noting that the authors did not
implement a cross-over design and could not account for individual variations in
performance. However, the study did implement a five-week supplementation
phase (versus 21 days in the current study), which would theoretically maximize
the treatment effect. At least ten other studies evaluated the efficacy of one of the
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primary constituents of SR2W-1 (Cordyceps sinensis, Eleutherococcus senticosus,
or Panax Ginseng), eight of which reported no change in cycling time to
exhaustion, time trial performance, or anaerobic power output. Thus it is logical
that SR2W-1, with all constituents combined, would not yield performance
benefits.
The effects of one to eight weeks of Panax Ginseng (PG) supplementation
at varying dosages was investigated by Morris (73), Allen (3), and Engels (25-27).
All five studies reached the similar conclusion that PG supplementation does not
benefit cycling performance. The different supplementation schemes and similar
testing protocols (high-intensity rides to exhaustion or graded exercise tests)
provide compelling evidence that PG is not ergogenic. Research regarding the
efficacy of Eleutherococcus senticosus (ES) on cycling performance is scant and
inconclusive.

Specifically, Eschbach et al. reported that 10-km time trial

performance was unaffected by 7 days of ES supplementation (1200 mg/day)
when compared to a placebo (29). In contrast, a subsequent study implemented a
much longer supplementation period (8 weeks) with lower dosing (800 mg/day)
and observed improvements in cycling time to exhaustion with ES (56). Another
relevant investigation, albeit with glaring methodological limitations (single blind,
possible learning effect), reported that time-to-exhaustion was enhanced with ES
(7). It is possible that ES may be ergogenic during high-intensity cycling but
further research involving different supplementation periods and dosages is
required before drawing firm conclusions.
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The results of studies investigating Cordyceps senesis (CS) and cycling
performance consistently show no ergogenic effect. Three CS supplementation
studies implementing exhaustive protocols of less than one hour found no
increase in time to exhaustion or time trial performance (15, 23, 76). Although
findings are not unanimous, the preponderance of literature suggest the primary
constituents of SR2W-1 do not benefit cycling performance of short duration (<60
min) which is substantiated by the results of the current study.
It is well-established that high-intensity cycling performance benefits from
lower blood lactate levels, as illustrated by the efficacy of bicarbonate
supplementation (11, 18, 47, 60, 62, 66, 67, 69, 77). However, to our knowledge,
only one study has provided any evidence to suggest that blood lactate levels are
diminished by herbal supplementation in the context of cycling.

Specifically,

Lahr and colleagues documented that SR2W-1 provision reduced lactate levels
during recovery from intense cycling. The authors speculated that less stress was
placed on the HCO3- buffering system with supplementation (57). However, it
should be noted that Lahr’s study did not use a cross-over design and can not
completely account for individual variation in performance.
Beyond the cycling-specific literature, a few studies have reported altered
lactate metabolism during high-intensity exercise with herbal supplementation.
Morrissey el al tested a complex herbal formulation using a double-blind,
randomized, placebo-controlled design and found that lactate was lower during
recovery from intense treadmill running (74). Further, Wu et al tested the efficacy
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of Ciwujia (ES) with high-intensity exercise and found lactate to be lower during
recovery while potentially promoting glycogen sparing (101). However, it should
be noted that Wu’s study, much like Lahr’s, did not employ a cross-over design.
The majority of studies, however, indicate blood lactate is not affected by PG (3,
27, 73), CS (23), ES (29), or alternative herbal (20, 52) supplementation. Further,
to our knowledge, our study was the first to examine skeletal muscle lactate levels
after herbal supplementation.

Considering the close association of blood to

muscle lactate levels at comparable observed time points (r = 0.67 - 0.91) in our
investigation, our novel findings confirm the validity of measuring blood lactate
to determine the state of muscle during exercise and reinforces the reliability of
our testing procedures. Provided the positive effect that lowered lactate has on
performance, the lack of alteration in blood or muscle lactate levels are consistent
with our performance findings as well as those found in the literature.
Of the studies that have evaluated similar physiological parameters (VO2,
RER, VE, HR, RPE, blood glucose, and skeletal muscle blood flow), there has
only been one report suggesting that herbal supplementation modifies highintensity cycling physiology. Kuo et al. found that VO2peak and highest heart rate
attained increased while RPE and RER decreased during a 75% VO2peak ride to
exhaustion with ES supplementation (56). Other data suggests VO2 (27, 29, 52,
73), RER (27, 52, 73), VE (15, 76), HR (3, 20, 23, 27, 29, 52), RPE (3, 20, 27, 29,
52), or blood glucose (29, 52, 73) remain unchanged with herbal supplementation.
Although Colson et al evaluated the effects of Cordyceps sinensis on circulatory
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dynamics during cycling and found no significant changes in tissue oxygenation
(15) we are the first to examine femoral artery blood flow in response to herbal
supplementation.

Increased blood flow to working skeletal muscle could

theoretically facilitate lactate clearance from skeletal muscle (8). However, our
findings suggest that blood flow is not affected by SR2W-1 supplementation,
which may or may not have contributed to our null performance and lactate
findings.
Contrary to our hypotheses, the results of the current study are consistent
with the existing literature, which collectively indicates that herbal
supplementation is not effective at improving cycling performance or altering
lactate levels. In addition, supplementing with SR2W-1 does not alter VO2, RER,
VE, RPE, blood glucose, or arterial blood flow during/following high-intensity
cycling.

The small sample size, supplementation adherence, and training

stipulations associated with the study present limitations to the generalizability of
our findings. However, the double-blind, placebo-controlled, cross-over design of
our study, in concert with the intensity of the cycling protocol and numerous
physiological parameters investigated, provides a strong basis for our conclusion
that herbal supplementation, SR2W-1 in particular, is of limited ergogenic value.

CHAPTER FIVE
SUMMARY
The primary aims of this study were to evaluate the effect of SR2W-1
supplementation on high-intensity cycling performance, blood and muscle lactate
levels, and a host of other physiological parameters (i.e. blood glucose, VO2,
RER, VE, HR, RPE, and skeletal muscle blood flow) utilizing a randomized,
double-blinded, placebo-controlled crossover design.

We hypothesized that

SR2W-1 supplementation would: 1) improve time to fatigue compared to a
placebo, 2) elicit lower blood lactate levels during a 20-minutes fixed-intensity
ride, high-intensity intervals, and recovery compared to a placebo, 3) elicit lower
skeletal muscle lactate levels during 15-minutes of passive recovery from highintensity cycling compared to a placebo, 4) increase skeletal muscle blood flow
compared to a placebo.
Contrary to our hypotheses, SR2W-1 did not improve high-intensity
cycling performance or decrease blood or skeletal muscle lactate levels.
Furthermore, there were no differences in blood glucose, VO2, RER, VE, HR,
RPE, and skeletal muscle blood flow with SR2W-1 supplementation compared to
placebo. Some possible explanations for a lack of efficacy include, but are not
limited to, a short supplementation period of 21 days, short duration of the cycling
protocol, difficulty adhering to the supplementation (pill ingestion every day) and
training stipulations (maintenance of training intensity and duration throughout
the study) required for participation, and a small sample size (n = 7).
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Notwithstanding these limitations, our findings indicate that SR2W-1
supplementation is of little ergogenic value.
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Appendix I

CYCLISTS WANTED
FOR
SPORTS SUPPLEMENT STUDY
The Human Performance Laboratory at JMU will be conducting a study
examining the effects of an herbal sports supplement on cycling performance,
muscle function, and lactate dynamics.
Who are we looking for?
- Males and Females
- 18-55 years old
- Cyclists (individuals performing cycling exercise on a regular basis – at least
3x wk)
What you will be asked to do:
- Complete preliminary fitness testing/screening (60-90 minutes)
- Participate in 5 exercise protocols (60-90 minutes), each of which consists of a
3 minute warm-up, 20-minutes of hard riding, 3 x 1-minute high intensity
intervals, 15 minutes of recovery, and a high intensity ride to fatigue lasting
approximately 5 minutes (~30-35 of total exercise)
- Receive laboratory assessments (including small blood draws, a muscle
function test or small muscle biopsy) during each trial
- Supplement for 21 days with an all-natural sports formula and a placebo (each
21-day supplementation period is separated by 10 days)
What are the benefits of participation?
- Free evaluation of aerobic capacity (VO2max) and physiological data
- $150 to $250 (biopsy subjects) for study completion
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For more information, please contact Dr. Nick Luden at ludennd@jmu.edu or Dr.
Mike Saunders at saundemj@jmu.edu
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Appendix II

James Madison University
Department of Kinesiology
Consent for Investigative Procedure

Purpose
You are being asked to volunteer for a research project conducted by Dr. Nick Luden, Dr. Michael
Saunders, Dr. Christopher Womack, Kevin Murach, and Tara Ata from James Madison University
titled “The Effects of an Herbal Supplement on Human Cycling Performance, Muscle Function,
and Lactate Dynamics”.
The primary aim of the current project is to examine the influence that 21-days of SR2W-1 sports
formula supplementation has on cycling performance, muscle function, and lactate dynamics.
Information gained from this project will help determine the efficacy of SR2W-1 as well as
indicate the underlying changes that are responsible for gains in cycling performance.

Experimental Procedures
You will be asked to report to James Madison University’s Human Performance Laboratory
(Godwin 209) for a total of six trials. Specifically, you will be asked to report to the laboratory for
one pre-testing/screening trial, one familiarization trial, and four treatment trials. Each of the six
trials will last approximately 60-90 minutes in duration. Detailed information for each of these
trials is provided below:

Pre-testing/Screening (n = 1 trial)

Before any physical evaluation is given, pre-screening forms will be completed to ensure that you
meet the study criteria, that you do not have any risk factors for heavy exercise, and that you do
not have any known allergies to local anesthesia. In the process of filling out these forms, you
will be asked to share information regarding your general health and lifestyle with the researchers.
If you meet the criteria for the study, the researchers will measure your height and weight and you
will perform a cardiorespiratory fitness test. During this assessment, an exercise test will be
conducted to determine your maximal oxygen uptake (VO2max). To do this, you will ride a
stationary cycle at an initial workload that is ‘fairly easy’. Workload will be increased every few
minutes during the test. You will be encouraged to continue to cycle until you request to stop due
to fatigue or are unable to continue at a cadence >50 revolutions per minute. Finger sticks to
obtain blood for analysis of glucose and lactate will be taken every two minutes during exercise
until fatigue. In order to be included as a participant in the study, you must achieve a VO2peak of ≥
40 ml/kg/min if female or ≥ 45 ml/kg/min if male. If you meet these criteria, you will be asked to
report back to the laboratory for a familiarization trial.
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Familiarization Trial: (n = 1 trial)
Within 14 days of the pre-testing trial, you will be asked to report to the laboratory for a
familiarization trial. This trial will be identical to the treatment trials, with the exception that no
blood or muscle biopsy samples will be taken. Please see the detailed description of the treatment
trials for a more complete understanding of the familiarization trial, noting again that no blood or
muscle biopsy samples will be taken.
Treatment Trials: (n = 4 trials)
Within 5-14 days of the familiarization trial, you will be asked to perform the first of four
treatment trials (TT). The treatment trials will take place before and after 21 days of sports
formula supplementation and before and after 21 days of placebo supplementation. You will be
randomly assigned to receive either 1000 mg/day of SR2W-1 or 1000 mg/day of placebo. The
SR2W-1 supplement is an all-natural sports formula comprised of herbal and fungi extracts and
the placebo capsule will look identical but will be filled with flour. You will be asked to ingest 2
x 500 mg capsules every morning for 21 days. To confirm compliance to supplementation, you
will be asked to text, e-mail, or call a specified member of the investigative team once a day after
the second ingestion (42 separate contacts). Ten days following the first 21-day supplementation
period (and treatment trial) you will be asked to replicate the first portion of the study with the
alternative supplement (placebo or SR2W-1). See next page for a general study schematic. For
each treatment trial, you will be asked to report to the laboratory in the morning after 10-12 hours
of overnight fasting. You will be permitted to drink water during the fast.

Treatment Periods:

Exercise Protocol
Each trial will last approximately 60-90 minutes in duration with the exercise protocol (shown
below) lasting approximately 50 minutes. Following a 3-minute warm-up, you will ride for 20minutes at a hard intensity (approximately 85% VO2peak), upon which you will be asked to
complete 3 x 1 minute intervals at an intensity associated with your VO2peak (determined during
the pre-testing trial). Each of these intervals will be separated by 30 seconds of riding at the same
intensity as the preceding 20-minute ride. Following the final interval you will be provided with
15 minutes of recovery. The recovery phase will be followed by a ride until fatigue performed at
an intensity associated with your VO2peak. You are encouraged to treat this aspect of the trial as if
it is a competitive event and to ride until you voluntarily stop or until you can no longer continue
at a cadence of 50 revolutions per minute.
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Exercise Protocol:

Blood Draws
A catheter will be inserted into a vein in the upper forearm approximately 10 minutes prior to the
exercise protocol. 15 blood draws will be performed at various timepoints during the protocol
and the catheter will remain in place until after the final blood draw. The catheter minimizes the
number of times that a needle is inserted.
During each sample, small amounts of blood (~3
milliliters) will be obtained and utilized to measure lactate, pH, and glucose. The total amount of
blood obtained during each trial will be approximately 39 ml or 180 ml over the course of the
entire study. This amount is similar to 50% of a can of soda or 38% of the amount given when
donating blood in a single session.
Metabolic Measurements
Metabolic measurements such as oxygen uptake, ventilation, etc. will be measured using a
SensorMedics metabolic cart. To do this, you will be asked to breathe through a mouthpiece/
breathing apparatus that collects your expired breath during the entire 20-minute fixed-intensity
ride.

Ratings of Perceived Exertion
You will be asked to provide subjective ratings of your exertion level at various timepoints
throughout the exercise protocol. You will do this by pointing to your corresponding level of
exertion (rated numerically from 6-20) on a Borg RPE scale.

Heart Rate
Your heart rate will be measured using a Polar heart rate monitor that will be worn around your
chest during each exercise session.

Skeletal Muscle Circulation
During the 15-minute recovery period, thigh blood flow may be measured with ultrasound
equipment – similar to what is done during fetal examinations during pregnancy. Ultrasound gel
will be applied to your quadriceps and a plastic ultrasound probe will be held in contact with the
skin for only a few minutes.

89

In addition to the measures outlined above, you are being asked to volunteer for either a
muscle function - central fatigue test OR a thigh muscle biopsy, as described below. The
muscle function-central fatigue test will be performed during the familiarization trial and
each treatment trial, while the muscle biopsy will only be performed during each treatment
trial.

Muscle Function – Central Fatigue Test
You will be asked to complete a maximal strength test prior to each trial, immediately following
the 3 x 1-minute intervals and towards the end of the 15-minute recovery period. During this test,
you will be seated in a modified chair, and asked to push as hard as possible against a shin pad that
will be connected to a force transducer for 4 repetitions with a minute rest in between. During
this strength test, you will also perform an electrically stimulated contraction. Two adhesive
patches will be placed on the skin of your thigh. These electrodes will be used to apply electrical
stimulation to the thigh muscle at an intensity, which produces a contraction force equal or greater
to what you can generate on your own. The stimulation intensity will be set below the maximum
stimulation intensity you can tolerate, similar to a TENS unit used in physical therapy.
________

I agree to participate in the muscle function – central fatigue test

Muscle Biopsy
A total of 4 muscle biopsies (one biopsy during each treatment trial) from the thigh will be
obtained for this study protocol. Prior to each biopsy, the skin at the biopsy site will be cleaned
with povidone-iodine topical anti-septic and numbed by an injection of a local anesthetic (similar
to what is done at the dentist). When the area is numb (5 minutes), a small 1/4 inch incision will
be made in the skin and a needle will be inserted briefly (2-3 seconds) into the muscle to remove a
piece of muscle about the size of a pea. The incision will be pulled closed with a band-aid and the
area over the incision will be covered with an elastic pressure bandage. The entire procedure will
take a total of approximately 10-15 minutes, with the actual biopsy lasting only a few seconds.

________

I agree to participate in the muscle biopsy procedure

Dietary and Exercise Controls
You are to maintain consistent dietary habits for 72 hrs prior to each trial, and to complete a diet
record (see Attachment 4) for the 24 hrs preceding each trial. While avoiding heavy exercise for
48 hrs prior to each trial, you will also be asked to maintain consistent physical activity habits
starting 72 hrs prior to the first treatment trial until the completion of the final treatment trial (~55
days), and to record all physical activity performed during the 72 hrs preceding each trial (see
Attachment 5). You are to consume your final ‘self-selected’ meal no less than 10 hrs prior to the
start of the treatment trials (i.e. dinner on the evening prior to testing). After this time, you are to
consume only water ad libitum until the end of each treatment trial (a total of ~11 to 13 hrs of
fasting with ad libitum water intake).
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Risks
You are expected to be honest about disclosing all known risk factors to the researcher. There are
no known risks associated with supplementing with the SR2W-1 sports formula. However, there
are some risks associated with high does of some ingredients in isolation. SR2W-1 is a proprietary
blend of herbs and fungi (primary ingredients: Enoki Mushroom, Eluthero Extract, Reishi
Mushroom, Tangerine Extract, Cordyceps Mushroom, and Asian Ginseng). Although highly
unlikely, it is possible that one or more of the ingredients can adversely impact pathophysiological
conditions (blood clotting disorders such as hemophilia or thrombocytopenia) or medications
(Coumadin, digoxin/digitalis). You will be pre-screened for each of the aforementioned conditions
as well as for known allergies to the ingredients. You will also be provided with an adverse event/
side effect form for you to record any adverse effects of supplementation.
According to the American College of Sports Medicine, the risks associated with maximal
exercise/testing for healthy individuals are very minimal. If you do not meet the criteria for “low
risk”, you will not be allowed to participate in the study. In the unlikely event of cardiac or other
complications during exercise, an emergency plan is in place. This includes immediate access to
a phone to call emergency personnel. In addition, each of the investigators is CPR certified.
The exercise protocol may result in minor-moderate levels of muscle soreness and fatigue for 1-2
days following each exercise session. However, the level of muscle soreness is expected to be
lower than levels normally experienced when people perform other ‘normal’ activities that are not
part of their regular exercise routine (i.e. if a cyclist played a game of basketball with friends for 2
hours).
The risks of blood draws include possible mild bruising, and the risk of transfer of blood-borne
pathogens. This risk is considered to be very minimal, and all safety precautions for handing
blood samples will be followed according to OSHA protocols.
The investigators have been
trained in phlebotomy and completed JMU blood-borne pathogen training.
The risks of the interpolated twitch technique include temporary “tingling” or “pulsing” sensation
(for 1-2 seconds), which you may perceive as uncomfortable.
The risks associated with the muscle biopsy technique include a possible dull pain during the
administration of the anesthetic and the biopsy procedure, and delayed soreness for one to two
days following the biopsy. Sterile procedures will be used during the biopsy procedure to
minimize these risks. There is a small risk of bleeding, infection, and scarring of the skin.
Temporary numbness of the skin near the biopsy site occurs rarely. You may feel lightheaded and
there is a slight risk of fainting. Following the biopsy you will be provided with a ‘biopsy care
package’ that will include instructions for care, band-aids, and alcohol pads. As a precaution, a
member of our research team will contact you via phone or e-mail approximately 48-hrs following
the biopsy to confirm that you are recovering/healing from the biopsy appropriately. You are also
encouraged to contact a member of our research team if you have any concerns about your
recovery. There is a small risk of an allergic reaction to the local anesthetic used during the
muscle biopsy procedure. Symptoms may include an itching sensation of the skin, difficulty
breathing, fainting, and shock. Allergic reactions to the local anesthetic used are extremely rare.
You will be pre-screened, as part of the medical history document, for any known allergic reaction
to local anesthetics.
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Benefits
The benefits associated with this project include a free VO2max assessment, and a $150 payment
for study completion.
If you volunteered to undergo the muscle biopsy procedure you will
receive an additional $100 payment for study completion for a total of $250. In the case that you
freely withdraw from the study, payments will be pro-rated as follows: non-biopsy subjects =
$37.50 for the completion of each treatment trial, biopsy subjects = $62.50 for the completion of
each treatment trial.

Inquiries
If you have any questions of concerns, please contact Dr. Nicholas Luden at ludennd@jmu.edu or
(540) 568-4069. In the case of any immediate concerns or adverse reactions during the study,
contact Dr. Luden on his cell phone (540) 746-6134.

Confidentiality
All data and results will be kept confidential. You will be assigned an identification code. At no
time will your name be identified with your individual data. The researcher retains the right to
use and publish non-identifiable data. All data will be kept secured in a locked cabinet.
aggregate results will be made available to participants upon request.

Final

Freedom of Consent
Your participation is entirely voluntary. You are free to choose not to participate. Should you
choose to participate, you can withdraw at any time without consequences of any kind.

I have read this consent form and I understand what is being requested of me as a participant in
this study.
I freely consent to participate.
I have been given satisfactory answers to my
questions. The investigator provided me with a copy of this form. I certify that I am at least 18
years of age.

Name of Subject (Printed)

Name of Researcher (Printed)

Name of Subject (Signed)

Name of Researcher (Signed)

Date

Date
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For questions about your rights as a research subject, you may contact the chair of JMU’s
Institutional Review Board (IRB). Dr. David Cockley, (540) 568-2834, cocklede@jmu.edu.
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Appendix III
AHA/ACSM Health/Fitness Facility Pre-participation Screening Questionnaire
Assess your health status by marking all true statements

History
You have had:
a heart attack
heart surgery
cardiac catheterization
coronary angioplasty (PTCA)
If you marked any of these statements in
this section, consult your physician or
other appropriate health care provider
before engaging in exercise. You may
need to use a facility with a medically
qualified staff.
pacemaker/implantable cardiac
defibrillator/rhythm disturbance
heart valve disease
heart failure
heart transplantation
congenital heart disease

Symptoms
You experience chest discomfort with exertion
You experience unreasonable breathlessness
You experience dizziness, fainting, or blackouts
You take heart medications
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Other Health Issues
You have diabetes
You have asthma or other lung disease
You have burning or cramping sensation in your lower
legs when walking short distances
You have musculoskeletal problems that limit your
physical activity
You have concerns about the safety of exercise
You take prescription medication(s)

If you marked two or more of the
statements in this section, you should
consult your physician or other
appropriate health care provider before
engaging in exercise. You might benefit
from using a facility with a
professionally qualified exercise staff to
guide your exercise program.

Cardiovascular risk factors

You are a man older than 45 years
You are a woman older than 55 years, have had a
hysterectomy, or are postmenopausal
You smoke, or quit smoking within the previous 6 months
Your blood pressure is > 140/90 mmHg
You do not know your blood pressure
You take blood pressure medication
Your blood cholesterol level is > 200 mg/dl
You do not know your cholesterol level
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You have a close blood relative who had a heart attack or
heart surgery before age 55 (father or brother) or age 65
(mother or sister)
You are physically inactive (i.e. you get < 30 minutes of
physical activity on at least 3 days of the week)
You are > 20 pounds overweight

You should be able to exercise safely
without consulting your physician or
other appropriate health care provider in
a self-guided program or almost any
facility that meets your exercise
program needs.
“Negative risk factors”

High-serum HDL Cholesterol ≥ 60 mg/dl

None of the above
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Appendix IV
Subject Prescreening Information
Please Complete the Following:

Gender: Male

Female (circle one)

Age (yrs):

Height (inches):

Weight (lbs):

Average Exercise Habits over the Past 2 Months:

Avg. # days of exercise per week:

Avg. # of days of aerobic exercise per week:

Avg. # of days of cycling per week:

Do you have a muscle or joint injury that precludes the completion of the exercise protocol?
Do you currently use medications for relief of pain and/or soreness?
Do you have a blood clotting disorder (haemophilia, thrombocytopenia, etc)?
Do you currently use blood-thinning medications (Coumadin, etc)?
Do you currently use cardiac medications (Digoxin, Digitalis, etc)?
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Are you allergic to any type of herbal supplement or one of the following substances?
Enoki Mushroom
Eleuthero Extract
Reishi Mushroom
Tangerine Extract
Cordyceps Mushroom
Asian Ginseng
Soy
Rice
Corn
Are you a vegetarian?
Are you allergic to local anesthetics (numbing agents) such as Lidocaine (Xylocaine,
Novocain, etc)?
Have you had Novocain administered at the dentist?
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Appendix V

24-HOUR DIET RECORD
Subject number____________
Date______________

Day of Week______________

Adapted From: Lee RD, Nieman DC. Nutritional Assessment. 2nd ed. United
States of America: Mosby; 1996
Time

Food and/or Drink Method of Preparation Quantity Consumed

Brand Name
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INSTRUCTIONS FOR KEEPING YOUR 24-HOUR FOOD RECORD
Keep your record for three days per trial. You will include the day before, the day
of, and the day after each trial. Include all meals, snacks, nibbling, and beverages
including water and cocktails

1. Fill out the date and day of the week at the top of food record sheet
2. Record the time you consumed your food and/or drink. To be most
accurate, fill out the food record as soon as you finish eating.
3. List the first food and/or drink you consumed when you began your day
and continue to record until you consume your last food and/or drink of
your day (usually before bedtime)
4. List each food and/or drink on a separate line
Example: cereal with milk, cereal and milk should each be on
separate lines spaghetti, noodles and sauce should each be on
separate lines

Combination foods:
List parts of food on separate lines
Include preparation method, quantity, and brand name of each food
Example: Sandwich (4 oz healthy choice turkey, 2 slices Sara Lee
wheat bread, 1 tbsp Hellman’s light mayo, 2 oz Kraft American
cheese, 1 slice of red fresh tomato)
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5. Record the method of preparation
Example: fried, baked, grille, salt, oil (olive, canola, corn, other)
butter or margarine, spices, etc.

6. Record quantity consumed
Do not record any food not eaten
Example: made two cups of vegetables but ate half so you would
record one cup
Quantity of food and/or drink
Example: cups, ounces, liters, grams, each, or other unit of
measure
Example: 1 cup of vegetables, 4 ounces of meat, one medium
apple

7. Record brand name
Example: fast food chain name and/or package name
Example: Wendy’s, Betty Crocker, Lean Cuisine, Gatorade,
Thomas Bagel

8. Place any helpful food labels in manila envelope that is attached to folder
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USE THE FOLLOWING TO HELP DETERMINE PORTION SIZES AND TYPES OF
FOODS
PLEASE SPECIFY

Beverages

Sugar or creamer?
Regular or sugar-free?
Alcohol content?
Name of drink and ingredients (if mixed drink)

Breads

Butter or margarine added?

Cereal/Milk

Milk, sugar, or fruit added?
The type of milk? (skim, 1%, 2%, whole)
Cereal: dry or cooked measure?

Dairy

Is yogurt fruited or plain?
% fat of milk or yogurt?
Indicate brand name of cheese substitute and/or

nondairy creamer.

Desserts

Whipped topping added?
Frosting?
Fat modified (i.e., reduced)?
Sugar-free?

Eggs

Preparation method (scrambled, hard-boiled, etc)?
Fat used in cooking?

Fast Food

What restaurant?
If not a national fast food chain, describe food in detail
Size order of fries? Super-size?
Extra toppings on sandwich?

Fats/Oils

Regular or salt-free?
Stick, tub, or liquid margarine?
Reduced calorie or diet product?

Fish

Water or oil packed (fresh or canned)?
Baked or fried (With batter or without)?
Type of fat added?
Raw or cooked weight?

Fruit

Sweetened or unsweetened?
Fresh, canned, or frozen?
With or without skin?

Meats

Visible fat removed?
Light or dark meat? Raw or cooked?

Sugars and Sweets

Regular or reduced-calorie?
Don’t forget hard candy as well as chocolate.

Vegetables

Raw or cooked?
Fresh, frozen, or canned?
Low-sodium or regular?
Added fat or sauce?

102
Helpful Hints with Portion Sizes
•
•

•

•

•

•

•

1 teaspoon (5 ml)
o about the size of the top half / tip of your thumb
1oz (28g)
o

approximately inch cube of cheese

o

volume of four stacked dice

o

slice of cheese is about the size of a 3 1/2 inch computer disk

o

chunk of cheese is about as thick as 2 dominoes

o

1 handful (palm) of nuts

2 ounces (57 g)
o

1 small chicken leg or thigh

o

1/2 cup of cottage cheese or tuna

3 ounces (85 g)
o

serving of meat is about the size of a deck of playing cards (3 exchanges)

o

the size of the palm of your hand

o

1/2 of whole chicken breast

o

1 medium pork chop

o

1 small hamburger

o

unbreaded fish fillet

1/2 cup (118 ml)
o

fruit or vegetables can fit in the palm of your hand

o

about the volume of a tennis ball

1 cup (236 ml)
o

about the size of a woman's fist

o

breakfast cereal goes halfway up the side of a standard cereal bowl

o

broccoli is about the size of a light bulb

1 medium apple = A tennis ball
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Appendix VI
Daily Activity Records
Subject #

Trial #
Date

Date:

Intensity of Exercise
Type of Exercise Performed Duration of Exercise
(minutes)
(use scale below)

Intensity Scale
6
7
Very, very light
8
9
Very light
10
11
Fairly light
12
13
Somewhat hard
14
15
Hard
16
17
Very hard
18
19
Very, very hard
20
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Appendix VII

Inventory of Supplies Necessary to Complete this Project
Pre-Screening Trials
Lactate Threshold Blood Analysis
Supplies Needed

Brand and Item Number

Sterile Alcohol Prep Pads

Fisher Brand: 06-669-62

Mini-capillary Blood Collection
Tubes

Ram Scientific: 07 6101

Unistik Lancets

Owen Mumford Ltd: AT 1013 CE053

Kendal Versalon All-Purpose
Sponges, 2 x 2

Tyco Healthcare Group: 9022
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Treatment Trials
Lactate Blood Analysis
Supplies Needed

Brand and Item Number

Excel Safelet Catheter Needles (20G
x 1 1/4”)

Superior Silver: EP85465

Baxter Standard Bore 3-Way
Stopcock

Med Specialties Distr.: 2C5600

Bacteriostatic 0.9% Sodium Chloride

Hospira: NDC 0409-1966-07

Monoject 6 mL Luer-Lok Syringes

Tyco Healthcare: 1180600777

Kendal Versalon All-Purpose
Sponges, 2 x 2

Tyco Healthcare Group: 9022
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Treatment Trials
Muscle Biopsy
Supplies Needed

Brand and Item Number

Biopsy Needle

Stille: 119-29187-50

Crosstex self-sealing sterilization
pouch

Fisher Brand: 01-312-51

Lidocaine HCl 0.1%

Hospira: NDL 0409-4276-02

BD 3 mL Syringe, Luer-Lok Tip

Becton Dickinson: 309585

23G TW Needles, Precision Glide

Becton Dickinson: 305193

Monoject Safety Needles, 20G x 1”

Tyco Healthcare: 8881850010

Safety Lock carbon steel surgical
blades

Bard-Parker: 371151

1” Durapore Tape

3M: 1538-1

Kendal Curity Gauze Sponges 4 x 4

Tyco Healthcare: 2187

Kendal Versalon All-Purpose
Sponges, 2 x 2

Tyco Healthcare Group: 9022

Betadine Swab Stick

Purdue Products: NDC 67618-153-01

Poly lined sterile field

Basse: 696

Elastikon Tape

Johnson and Johnson: 005171
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Supplies Needed

Brand and Item Number

Coban

3M: NDC 8333-1582-01

Maxizyme

Henry Schein: 101-9031

Kenal 140 mL Luer-Lok Syringe

Tyco Healthcare: 8881114063

33” Tubing, latex free

Smiths Medical: 2009-12
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Treatment Trials
Tissue Processing
Supplies Needed

Brand and Item Number

Disposable Scalpel, #10

Feather: 2975

Cryo Tube Vials

Nunc: 375418

Petri Dishes for 47 mm cultures

Fisher Brand: 09-720-500

Kendal Curity gauze Sponges 4 x 4

Tyco Healthcare: 2187

Dulmont Medial Tweezers, 110mm,
#5

Ted Pella, Inc.: 38125
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